introvivo works by stopping the virus from multiplying and infecting people with hepatitis c infection . incivo is used to treat chronic hepatitis c in adult patients ( aged 18 years and older ) who have already received peginterferon alfa , ribavirin and telaprevir . incov belongs to a class of medicines called ns3 - 4a protease inhibitors . the ns3 , 4a protein inhibitor stops hepatitis c virus from growing and infects other cells . it is used in combination with peginerferonalfa and ribavir . how incivo works incivo targets a protein called
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin by your doctor . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : - if you know that you may be at increased risk of experiencing severe side effects 56 - if your doctor has prescribed the medicine alfuzosin for you because of symptoms of an enlarged prostate . - if any of your doctor ' s prescribe alpha - 1 - adren
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage always take the appropriate dose regimen exactly as described in this leaflet . the recommended dose regimen is 3 mg twice a day ( 6 mg twice daily ) taken in the morning and evening , followed by 2 mg twice weekly ( 8 mg twice every day ). your doctor will tell you the dose to take . the dose may need to be adjusted by your doctor if you have both hepatitis c virus infection and human immunodeficiency virus infection ( hiv infection ). efavirenz take the recommended dosage
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe and may be life - threatening . other symptoms of the rash : a severe skin reaction tell your doctor immediately if you develop a skin rash . if your rash is severe and you experience other symptoms that might be life threatening , such as a rash , fever , tiredness , swelling of the face , swellingof lymph glands , a wide - spread rash , peeling skin , fever and flu - like symptoms , painful skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo delivers 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinbaa is used for zinbolta is used to treat multiple sclerosis in adults . it is used in combination with therapy ( two ms treatment ) or other treatments to reduce inflammation and the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can be characterised by repeated attacks ( relapses ). symptoms that are not controlled by your nerves
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking zinryta . liver problems talk to you doctor , pharmacists or nurse if you are suffering from any other autoimmune disorders . you should not take any other medicines , including herbal supplements . tell your doctor if you take any medicines , especially supplements that may increase liver side effects . these medicines should be taken with caution . if you think you may be taking zirin
your doctor will decide how much zinbryta you need and how often you need to take this medicine . the recommended dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your first dose of the first dose is one 40 mg tablet once a week . your dose may be increased depending on the results of this blood test . your next dose may need to be adjusted . your first treatment will be a blood sample taken before you start taking zina . injecting yourself zinbuq is given under
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ): severe inflammation of the liver may lead to death . tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . if you are using a new syringe / pen , do not put it in a fridge . zin bryta syringes / pens are not to be stored above 30 Âºc . store
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection contains 150mg of dlizumb beta . 1ml solution for infusion contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbenta is a clear to slightly yellow , colourless solution for injecting in a syringe / pen
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver into the eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and its further accumulation in the body . wilston ' s diseases is not a cure for any of the following conditions . your doctor will discuss with you the benefits of this treatment .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will decide whether wilzin should be used for the initial treatment or in combination with other anti - copper agents , penICillamine , depending on your symptoms and whether the treatment is adequately tolerated . monitoring of blood and urine will be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg / 50 mg once a day . your doctor will prescribe the dose that is right for you . the dose will depend on your condition and body weight . the usual dose is 1 mg wilzin 50 mg / 2 mg wilz 25 mg once daily . your dose will be adjusted by your doctor . the doctor will decide the dose to be taken with or without food . the starting dose is one 25 mg capsule once a morning . your
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): frequency not known : frequency cannot been estimated from available data not known from the data reporting of side effects if you get any side effects talk to your doctor ,
keep out of the reach and sight of children . do not store above 25 . do this after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg of the zinc acetate dietrate . the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg "
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active substances are emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretraviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults . infection with hiv may improve your immune
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you think any of them apply to you , tell the doctor or pharmacist . warnings and precautions talk to your doctor or nurse before taking bikarvy : - if you have ever taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be adjusted with aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron . see section 2 " important information about these medicines and biktarvy " for further information . if you take more bikarvy than you should if you accidentally take too many tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms are usually due to an improvement in the body ' s immune response , enabling the body to fight infections that have no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are common . medicines given to treat hiv illness can cause autoimmune disorders many
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtracitabrine and ten ofovir aluminium afenamide fumarate equivalent to 25 mg tenofavir alufenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when you start to take novonor on its own or in combination with metformin . if you have diabetes , no
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will check the acid level in your blood regularly to avoid diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell your doctor . if the doctor has given you gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you suffer from liver problems . novonors should not be used in patients with moderate liver disease , as
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily . if you take more novonor than you should if you have taken more novones than you were told to , talk to a doctor or go to a hospital straight away . if possible , take the tablet with food . you may take no vonorm with food or between meals
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypoemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) ( see section 2 " novonors contains sodium "). what novonor looks like and contents of the pack novonOR tablets are white to off - white , round , flat , with " 0 .
what pumarix is pumarood is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemic fluids are similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarax may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( e . g . chicken protein , ovalbumin , formaldehyde , sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop using the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarax may occur . if this happens , stop having this vaccine and talk to your doctor
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those in adults 18 years of age and older who are not able to have a vaccine . pumix is used in children aged 3 - 9 years and adolescents aged 10 - 17 years . how pumarx is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the place of thejection has been given
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the suspension should be used immediately . if the vaccine is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the suspension once it has been thawed . do throw away
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is a component of the pandemic vaccine ( an ' adjuvant ' as03 ). this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections . what pumarax looks like and contents
what somakit t is somakiton t is a radiopharmaceutical product containing a substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . what somakt t is used for this procedure the active substance is gallium . edotreaotide is injected into a vein ( subcutaneously ) into the body areas . this is a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the use of somaknit t does involve exposure to
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any ingredient listed in the section 4 of this leaflet . warnings and precautions talk to your doctor or pharmacist before taking somakttoc if : you have kidney or liver problems you have renal or hepatic disease ( see section " warnings and actions "). children and adolescents somakattoc is not recommended for children and teenagers under 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . you
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of somakttoc and will keep you informed of their actions . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somackittoc to be administered . the usual dose is 100 to 200 megabecquerel per kilogram of body weight . the administration of somaksittoc is in accordance with national regulation on radiolabelling
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the site of the injection may be exposed to low amounts of ionising radiation ( for example , for cancer or hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done by the specialist . somakit t will be stored at a temperature not above 4 and below 25 for a single period of maximum protection from light . do not use somakt to expose the product to radiation because it may pose a risk to the environment . do this because it is radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide and water for injections . - the solvent contains sodium ( e507 ) and radiolabelling . - after reconstitution , the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somakt t is presented as a kit for radiopharmaceutical preparation . it is
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows down the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , when non - steroidal aromatase inhibitors ( such as steroids ) have failed to control the disease under control . afenitor is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours ) in the stomach , bowels , lung or pancreas
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit if you : are allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions you should tell your doctor before taking the first dose of afininitor : if you have any problems with your liver . if you suffer from any disease affecting your liver , your doctor may prescribe a different dose of Af
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor once daily . if you have liver problems , your doctor may prescribe a lower dose of afginitor ( 5 mg ) once daily , or alternatively , a higher dose of 5 mg once daily ( 7 . 5 mg ). if you experience certain side effects , your dose may be reduced . your doctor will monitor you more closely during treatment . if necessary , your physician may reduce your dose of the medicine to a single tablet once daily depending on your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your physician immediately . other side effects of afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature ( chills ) - infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after opening . do this medicine if you notice any visible sign of tampering . do so and return the tablet to your pharmacist . do away with the blister and any unused tablet after this time period . do throw away any medicines via wastewater or household waste .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each film - coated tablet contains 5 mg of of everlimus . the other ingredients are : tablet core : hypromellose , crospovidone , lactose anhydrous . what afinitors looks like and contents of the pack afinator 2 . 25 mg tablets are white to slightly yellowish , oval , biconvex , bevelled tablets . afintitor 5mg tablets are supplied as
what laventair ellipta is the active substance of lavent air ellipta , is umeclidinium bromide , vilanterol . this belongs to a group of medicines called bronchodilators . what laventAir ellipta used for laventive ellipta was prescribed for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your asthma is getting worse . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : - for asthma - if there are heart problems or high blood pressure . - if any of these apply to you . - for an eye problem called narrow - angle glaucoma . - tell your doctor if you have an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . try to use it at the right time each morning and evening . if you use more lavent air ellipta than you should if you have used more lavents than you need , contact your doctor immediately . symptoms of using too much laventAir ellipta may include a sudden attack of breathlessness or wheezing . if
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ) feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing difficulty stop using this medicine and contact a doctor
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umemlidinia ( equivalent to 65 microgram ) umelidinIUM bromate and 22 microgram s of vilancerol ( as trifenatate ). - the other ingredient is lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an
what tremfya is tremfYA contains the active substance guselkumab , which is a monoclonal antibody . this medicine attaches to a protein called il - 23 , which helps to protect the skin from light . what tremfia is used for tremfiya is used to treat adults with psoriasis . it is used in adults with moderate to severe " plaque psor psor " which is an inflammatory condition that affects the skin and nails . it helps to improve the condition on the skin , and the appearance of nails .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to the doctor or nurse before using this medicine if you : have an infection or an infection with tuberculosis 36 have an illness with symptoms of an infection you are not sure if you can get infections from this medicine . allergic reactions may occur during vaccination . if you receive a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . you should not inject tremfia more than once a week . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). persistent or recurrent ctph is characterised by surgical treatment , poor exercise capacity and symptoms of the disease . chronic thromeboembolmonary hypertension is caused by a condition in which blood pressure is too high , which affects the blood vessels of
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is only available in hospital . it is only suitable for patients who are able to use a portable pump . you should always use your treprostinil with the pump provided in the infusion line . in order to reduce the risk of accidental overdose , the recommended dose is 1 mg , 2 . 5 mg ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with the vial . do this if it is accidentally frozen . do use trepulmix vial immediately after preparation . if it has been frozen for more than 30 days , it should be used as continuous subcutaneous infusion in a single reserve ( syringe ) of undiluted trepulemix within 72 hours
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial delivers 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials delivers 2 . 25 mg trepistinill ( as salt ). one 10 ml ampoule delivers 25 mg of treprosticinil ( ( as hydrochloric acid ) and sodium salt . one trepulamix 5 mg : one vial provides 5 mg treProstinIL (
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two different ways : 1 ) to prevent existing blood clots from forming and 2 ) to stop blood cl clots forming in your blood . thorinne is used to prevent blood clumps from forming in the blood after an operation . it can be used : - if you have an acute illness called unstable angina ( problems with your heart ). - if your heart has been working poorly . - if a heart
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heparrin , such as a severe drop
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor or nurse straight away if you notice any bleeding event that is unusual or unusual . excessive bleeding may be characterised by exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling . tell the doctor immediately , or stop your medicine . if you have any of the following while taking thorinan : - a severe allergic reaction , which may cause difficulty breathing , swelling of the lips , mouth , throat or eyes , blockage of a blood vessel or a blood clot , cramping pain , redness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each ml contains 100 mg of enoxapearin sodium in each pre - filled syringe . each 0 . 2 ml pre -filled syringe contains 2 , 000 mg of the active ingredient enoxagarin sodium and is for single use only . after dilution , the solution for injections is stable for one single use period of 0 .2 ml . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber
sensstend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to be completed .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have allergy or sensitivity , ask your doctor for advice . warnings and precautions talk to your doctor before using senstent if you have been treated with local anaesthetics ( amide - type local anahetics ). if your doctor has told you that you have a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). medicine sensitivities and sensitivity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per cm2 ) taken once a day . the first dose is 1 spray in the head of your penis . after 3 sprasters , the second dose is 24 sprays per cmÂ² ( 4 sprays in the same cm2 ). the spray container should be used immediately after the pump mechanism has been changed . avoid direct contact with eyes , nose , mouth and ears . after the first
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may affects up to 1 in 100 people ) headache local irritation of the throat or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the place of the penis itching in the position of your erect penis a high temperature other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this time period . donot puncture or burn the container . do this to avoid tampering . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml lidocane and 7 . 5 mg prlocaine , each spray container containing 2 . 5 ml prilacaine . - each spraycontainer contains 6 . 5 to 20 ml of spray . - the other ingredients are : - powder : water for injections . - solvent : solvent : water . - clear , colourless to light yellow cutaneous spray . what senstends looks like and contents of the pack
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma is advanced and can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , nivolumab , is
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivio if you : - have problems with your heart , such as a change in the rhythm or the heartbeat of your lungs ( an abnormal heart rhythm ) - have any problems with any of your lung systems ( breathing difficulties or cough ) - inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea - watery , loose or soft stools - any symptoms of inflammation of any intestines (
how much opdivo is given the recommended dose of opdivone is 240 mg given as 2 mg once a day ( corresponding to 480 mg per 4 kilogram body weight ). how often opdivon is given ipilimumab will be given to you depending on how you respond to the treatment . for skin cancer the recommended doses of opDivo are 1 mg of nivolumab per kilogram of your body weight . the recommended daily dose is 4 mg of opilimuma per kiloreweight . for advanced kidney cancer the dose of ipdivo will be 3 mg of the same dose as niv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 - 10 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivly ( 240 mg /ml ). each 24 ml vials contains 240 mg of the active substances niviolumab and the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel tad 30 - if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of clopridogrel tetad , ask your doctor or pharmacist . warnings and precautions the warning and precautions of clapidogel tad are
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopIDogrel tetad looks like and contents
tacforius contains the active substance tacrolimus . it is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius will help prevent rejection of the transplanted organ by your liver and kidneys , and will improve your condition if your body's immune system is able to accept the new transplanted organs . tacfortius will prevent rejection by your transplanted liver and heart by rejecting any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacni ) are not available . tacforia prolonged - release capsules are not recommended for use in children and adolescents under 18 years of age . tacorlimus immediate - release capsule are not suitable for use by children and adolescent . tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant , your doctor may prescribe a different tacrolemus medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafleon to make sure you have the right medicine . the dose you take will depend on the severity of the rejection caused by your transplanted organ .
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you will be monitored for infections while you are being treated with tacforius . severe effects may occur , including allergic and anaphylactic reactions , benign and malignant tumours , which have been reported during tacforia treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ), febrile neutropenia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month after opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforia 1 mg : one capsule contains 1 mg of ticrolimas ( asohydrate ). each capsule of tacforio 3 mg : three capsules contain 3 mg of of tacrulimus (as monohydrate ) . each capsule capsule of the 5 mg capsule contains 5 mg of tartar ( asmonohydrate ). the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lactose
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following apply to all people taking clapidogel zentva : if any part of the treatment reduces the risk of bleeding :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with clopidogrel zentiva if it is accidentally frozen . aluminium blisters : do not store above 30 . doxorbed on aluminium blays : dox or off - white . do xorbed upon aluminium blinks : do xarbed on all aluminium blks . donot use this medication if
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopiderel zenta contains lactose ' and ' clopsidogl zentva contains hydrogenated castor oil '), mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), tri
yttriga is a radioactive medicine that is stored in a refrigerator ( 2 - 8 ). it is used in combination with another medicine for tiny radiation doses . the treatment is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrada - yttrida is a radioactive medicine . it is not used in combination with another medicinal product . - radiopharmaceuticals are not to be used in this way . - ytriga contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and yttarga tell your nuclear medicines
the treatment will be initiated under the supervision of a physician experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga is intended for use by adults only . if you have been prescribed yttrada by your doctor , you will be carefully monitored for signs of overdose and will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttiga is a clear , colourless to pale yellow solution in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains the active substance cisplatin , another anti - cancer medicine , which is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cinembra is used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if ciamra is suitable for you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy
do not use ciambra : if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciambreed ( listed in section 6 ). if you plan to stop breast - feeding during treatment with ciamBra . if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamb if you or your family has or have had problems with your kidneys . before you are given ciamba , your doctor will check your blood and the function of your kidney and liver function to make sure that you have
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and body surface size . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) if you suffer from allergic reaction ( common ). if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . do this immediately after preparation . if the infusion solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 , 15 and 25
what ciambra contains the active substance is pemetrexed . each vial of ciamra 100 mg contains 100 mg of pemetreed ( as pemetresed disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretrexed dis sodium hemipontahydrated ). after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare professional is required prior to administration . the other ingredients are mannitol ( e421 ), hydro
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help to control certain infections in your blood . immunogams can be used in adults to prevent increased levels of human hepatitis b immunoglubulins , such as immunoglofulin g ( ig ) in the blood plasma of screened adults . immunoglogam is used in combination with hepatitis b virus in haemodialysed patients . vaccination is a precautionary measure . a hepatitis birus carrier may produce an immune response that suppresses the production of measurable hepatitis b antibodies . vaccination and continuous prevention are
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products . - if your child has an iga deficiency . - an allergic response to iga containing products . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin may cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also be severe ( including nausea and arthralgia ). - if the child has joint pain or low blood pressure , or moderate low back pain . antibodies
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in accordance with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 mg given every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 Î¼g given every 2 weeks . seroconversion is recommended . vaccination against patients with hepatitis b will be initiated by a hepatitis birus carrier . the hepatitis b antigen will be prepared by the healthcare provider
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects have occurred during clinical trials with immunovogam . the injection site is usually smooth and painless . common ( effects
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogams 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( as polysorbate 80 . see section 2 ). what immunogaman looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older . these diseases
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take more remicADE than you should if you accidentally take too many remicad tablets , contact your doctor or pharmacist immediately . if possible , show them the pack
the recommended dose for adults is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of skin weight . how remicade is given remicades will be given to you by your doctor or nurse . how it is given the medicine will be prepared and given to your doctor by a healthcare professional . it will be administered as an infusion ( drip ) over 2 hours into one of your veins
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you experience any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction ( e . g . swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles ). these reactions are rare but could be life threatening . an allergic allergic reaction may occur in more than 2 in 10 people
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicades may be used for infusion , for example if it is stored at room temperature ( up to 30 ) for a single period of 3 days ( but not above 2 ). if it has been stored at or below 28 for a longer period of 28 days
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicada is supplied in packs containing 1 , 2 , 3 , 4 or 5
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine that is produced in the cells and helps to maintain a balance of movement . raspagilmine mylan helps to increase the amount and timing of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasagailine or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a strong pain killer . it may affect the way some other medicines work . rasaggiline melan treatment may be interrupted or stopped if treatment with mao inhibitors ( such as p
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at the same time each day . swallow the tablet whole with a glass of water . you can take rascagilide mylan with or without food . if you take more rasaga mylan than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasgiline Mylan carton . if more rashes are seen than you have
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth ,
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline Mylan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , such as tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . if the patient has a serious heart condition . warnings and precautions allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and usually disappear within a few days . infections tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio is 20 mg once daily . in children from 2 - 17 years of age weighing 30 kg or less the usual dosage is 30mg once a daily . hula is 40 mg once in a day when taken in combination with enthesitis - related arthritis in children 6 to 17 year old weighing 15 kg or greater the usualdose is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur within 4 hours of the last hulio injection ): allergic reaction ( e . g . heart failure ) severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hullio looks like and contents of the pack hulios 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hulIO is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilile
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed a medicine for asthma ( skin allergy ) or intense inflammation in your nose . - if using other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( cortisone ) which may increase the risk of unwanted side effects . - bleeding problems ( such a condition as haemophilia ) in the past . -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye ( s ) once a day . the recommended daily dose is 2 drops in the treated eye (s ) once daily . the drops should be used the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , between the head and eyelid .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for single use only . you should swallow the tablet whole with a drink of water . do not chew or crush the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the tongue
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : - severe breathing problems , especially slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may affects up to 1 in every 10 people ) - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do discard any medicines that are not used immediately . do throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvo looks like and contents of the pack dzu veo is a white to off - white , round oval tablet with " nvr " on one side and " 3 " on the other side . it is supplied in
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original body and is not resistant to surgical treatment . it reduces the levels of testosterone in the blood and reduces the risk of developing resistant prostate cancer . erleada also reduces the amount of androgens in the body . this reduces the chance of the cancer coming back . by reducing the levels androgens , apalutaamide stops prostate cancer cells from growing and dividing
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if if you think you may be pregnant or are planning to become pregnant ( see pregnancy , breast - feeding and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine may cause seizures . tell your doctor if you : - are taking any medicines that prevent blood clots ( e . g . warfarin or acenocoumarol ). - have any heart or blood vessel conditions , such as heart rhythm problems ( arr
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet and this medicine by mouth . you can take erleade with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erLEada if you miss a dose of erlea , take it as soon as you remember .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious sideeffects . fits ( seizure ) uncommon
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in the film - coating : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide . what erlead looks like and contents of
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adults who have previously had treatment for prostate cancer . it can be used in combination with other tests to determine prostate specific antigen ( psa ), which are used to determine the cancer . an axumin pet scan is performed to find out if the cancer has spread to other parts of the body . the scan will be recorded on the patient ' s patient alert card . your doctor or nurse will record the results of the scan . your nuclear medicine doctor will decide if
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . before you are given axumin , you will have a day to prepare the axumin scan . this is called a " rest period ". you will then have 4 hours before the scan . - do not change your usual medicines or take them at the latest 60 minutes . - after the axul
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . how axumin is given and the procedure axumin must be injected into a vein ( intravenously ) by a flush
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , side effects were seen in 1 to 100 patients treated with the medicine . the following side effects have been reported with axumin in 1 - 100 patients : pain , rash , altered taste in the mouth , altered sense of smell . the frequency of these effects is not known . the safety and efficacy of this radiopharmaceutical have not been established . ionising radiation is a very sensitive target for cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( corresponding to 1600 mg / 16000 mg ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( correspondingto 3200 Î¼g / 32000 mg ) - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off - white powder for solution for injection . axum 1600
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some people : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if this happens to you , tell your doctor . warnings and risks talk to the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use azopt in both eye and eyes : 1 drop in each eye . use in both of eyes : 2 drops in each eyes . 1 drop of azopt per day . use the azopt bottle with your hands . remove the cap . the cap is attached to a snap collar . hold the bottle tightly with both hands . tilt your head back and pull down your eyelid with a clean finger until there is a ' pocket ' between the eyelid and the back
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) â effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines ( medicines taken by mouth ) used to treat diabetes by controlling the level of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ). forxigo is used to control diabetes in adults . type 1 diabetes is a problem that occurs when your body does not produce any insulin . forxige is used for the treatment of type 1 in people who are overweight or obese . type 2 diabetes : your body hardly makes enough insulin , and the insulin that your body makes does not work as well
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away : - feeling sick or being sick ( stomach pain ), excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is for oral use . for type 2 diabetes : the usual dose is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of forxigo is for single use only . for the type 1 diabetes : your doctor will increase your daily dose to 5 tablets a morning . taking this medicine swallow the tablet whole with a glass of water . for xiga can be taken with or without food . your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are : angioedema ( very rare , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( very common , may affects more than 1 in 1 , 000 persons ) if you have type 2 diabetes , your blood may become thinner ( see section 2 ). if you are sick ( being sick ) with stomach pain , excessive thirst , fast and deep breathing , confusion ,
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( k171 ),
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged between 2 and 30 years . it is used when surgery is not possible or cannot remove the tumour . it can be used alone or in combination with chemotherapy which destroys cancer cells and keeps the cancer at a low level . it also helps to bring the cancer back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) or nsaids . warnings and precautions talk to your doctor or pharmacist before taking mepactor if you : have problems with your heart or blood vessels , including blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). mepaction treatment can cause long
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . this dose is given every 12 hours . your doctor may change your dose up to 24 hours depending on how you respond to your mepacts treatments . your chemotherapy schedule will be adjusted by your doctor . your dose may be adjusted if your chemotherapy is interrupted or your chemotherapy has to be stopped 36 hours after you finish treatment with mepat
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepacts ( transient ) paracetamol . if you experience fever during treatment with mepACT , tell your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have been seen in patients receiving chemotherapy . tell your physician immediately if you have continuing fever and chills . these may be signs of an infection . rash tell your doctors immediately if any problems breathing , wheezing or any stomach problems get worse . very common side effects ( may affect more than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartons in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 25 ) for up to 6 hours . do this medicine if you notice any visible signs of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 ' mepacts contains lactose '), 2 - dileoyls - sn -glycero- 3 - phosphate - l - serine monosodium salt ( see also section 2 "
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it works by reducing the amount of blood that reaches the skin and causing redness ( rosacea ), which is associated with redness of the face . rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , which prevent the excess blood flow and redness from occurring .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin ( subcutaneously ) - if your doctor has told you that you are taking certain medicines used to treat depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin on the face . this medicine is applied by a gentle touch to the surface of your body . it is applied on your body surfaces , such as your eyes , mouth , nose or vagina . if you use more mirvasoe than you should if you have used more miraso mirvasos is applied only to the face once a day . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your symptoms do not
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms persist ( see section 2 " warnings and precautions "). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mir
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and pumps after first opening . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonidine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparasahydrobenzoates "), propylene Glycol . what mirvasoa looks like and contents of the pack
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system and is used in the body to fight infection and cancer ). bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the veg f protein causes blood vessels to expand , thus allowing blood vessels and oxygen to be taken out . bevaconizumib slows tumour growth and allows blood vessels ( the
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your doctor thinks you may have an increased risk
dose and administration the dose of mvasi you will receive will be calculated based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor will decide how many infusions you need based on the size of your bodyweight . how often mvasia is given your doctor may decide to give you mvasis every 2 or 3 weeks . how many treatments you will have depending on how you respond to treatment , your doctor or nurse will decide when you will be given this medicine . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below are caused by the side effect of mvasi combined with chemotherapy . if you notice any of these side effects while you are being treated with mvasic , tell your doctor straight away . allergic reactions tell your physician straight away if you have an allergic reaction including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects ( may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions may be stored for up to 24 hours at 2 to 8 , when stored in a sterile environment . after dilution in a steril environment , the product may be used immediately . if not used immediately , in - use storage times and conditions
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevocizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevucizumumab in 1. 4 ml . each 16 ml vials contains 400 mg of of bevagacizumaab in 16 . 75 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack m
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . tecartus works by inhibiting the growth of refractory mantle cell cancer ( b - lymphocytes ) in your own white blood cells . it works by blocking the growth and spread of autologous anti - cd19 - transduced cd3 + cells . mantle cell lipoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - cells . in mantle cell lemphoma , b - lipocytes multiply
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have ever had problems with white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ). - have a problem with white cells being collected for autologous use . - have had tests or checks of your lungs , heart , kidney or blood pressure . - had infection or inflammation of your cancer ( graft - versus - host disease ). -
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your white blood will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your whiteblood cells will then be collected from your blood . the first dose of your blood will go into your vein over 3 to 6 hours . the number of your white cells will depend on how well you respond to the medicine . the second dose will be taken over 2 to 3 hours . medicines given before tecartus treatment ( lymphodepleting chemotherapy ) the modified white
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may be associated with confusion , memory loss , disturbances
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . the product is stable for 36 hours at 2 - 10 . do throw away any medicines via wastewater or household waste .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 x 2 cd3 cells per ml . - the other ingredients are : 106 anti - dcp3 + sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartucus is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag made of a
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar because your type 2abetes is getting worse . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glitaz
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have any of these conditions : - if any of those conditions ( listed under section 4 ) have been reported as blistering of the skin ( bullous pemphigoid ). januv may cause a disease of the pancreatreas called pancreatitis ( gallstones ). - you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film coated tablets . your doctor will tell you the dose to take . taking this medicine your doctor can tell you to take this other medicines to lower blood sugar . diet and exercise januvia is for oral use . swallow the tablet whole with a glass of water . you can take januva with or without food . if
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting ( these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop taking
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what januva looks like and contents of
what xultophy is xultue is a low - sugar type of insulin that helps to control blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin to control the level of sugar in the blood . the insulin that your body produces does not work as well as it should . it helps to lower blood sugar . it can also be used alone . insulin degludec ( a long - acting basal insulin ) helps to keep your blood sugar levels under control . liraglutide ( a type of glp - 1 ) helps you to
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you 39 are taking a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced so that your blood sugar levels are not too high . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you have type 1 diabetes mellitus or ' ketoacidosis ', a condition which can occur after you start taking xulinophy . inflammatory bowel
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for as long as your prescribed dose . you must take it every day for as little as 8 weeks . if necessary , you may take it with or without food . if your doctor advises you to take xulophy with or just after food , drink , and exercise , you should continue to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low blood glucose , your blood glucose level may be too low ( see section 2 under ' warnings and precautions '). if you experience signs of low bloodugar ( hypoglycasemia , see section 4 under ' serious allergic reaction '). signs of anaphylactic reaction ( frequency
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at 2 8 for a maximum of 21 days . do away with the blister once you have opened it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin deglioudec 10 . 8 mg liraaglunide in 3ml solution . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ] ( erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working and stops them from growing . this helps to stop cancer cells from growing and dividing . this medicinal product is used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment in adults who have not received prior chemotherapy treatment
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think any of these apply to you , tell your doctor before taking giotrinif . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have lung inflammation ( interstitial lung disease ) have liver problems your doctor may need to change your dose or perform some liver tests before you start taking this medicines if you suffer from a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrinif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( see section 2 under ' warnings and precautions ') severe diarrhoee with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( see below under ' serious and worsening kidney function ') if you experience diarrhoeea or diarrhoegoes , you should contact your doctor immediately . appropriate antidiarrhoeal treatment should
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotraif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in cystic Fibrosis transmembrane conductance regulator ( cftr ) cells in the lungs . the mutation causes an abnormal cftR protein that cannot be detected by your body ' s own light . how orkami works lumacftor works by blocking the abnormal
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that the f508del mutation is present , your doctor may need to change your dose of orkandemi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of andkambie . if any of these apply to you , tell your doctor . abnormal blood tests of the liver may occur
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults and adolescents the recommended dose is 6 to 12 tablets once a day . your doctor will tell you how many tablets to take . the recommended orkambi tablet is one tablet once a morning . this is about 6 to 11 hours before orkammi is taken . the dose may be adjusted by your doctor . the maximum recommended dose of 100 mg is 2 tablets once daily ( 2 tablets in the morning and 2 tablets at bedtime ). if you take more orkabi
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . however , if you are given ivacaftor , you may experience some of the following effects while taking orkammi : serious side effects while you are taking or kambi : raised levels of liver enzymes in the blood which can increase the risk of liver injury in patients with pre - existing severe liver disease and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacftor or 125 mg ivacftir . each tablet of orkmbi 200 mg film â coated tabletseach tablet contains : 125 mg or 200 mg lumasaftor or 150 mg iviacaftor . each film - coating of orkyambi 100mg or 125mg film - coat of or kambi 200mg or 150mg film â coating of cellulose , microcrystalline , croscarmellose
what lynparza is lynparanza contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of cells with mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death of cancer cells by stopping an enzyme that helps repair dna . what lynparlee is used for lynparZA is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is used
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynarza if any of these apply to you . if you think any of this applies to you , tell your doctor or pharmacist before you receive lynparz . if any part of the above applies to your child , tell the doctor or nurse straight away . if your child is not sure , talk to the doctor , nurse or pharmaceutist before you have this medicine . if
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on your response to the doses of lynarza capsules . your dose may be adjusted by your doctor . if you take tablets , you may take a capsule with or without food . if possible , take the tablet with a glass of water . if necessary , take it at least 8 hours after you take your last dose of the day . you can take the tablets with
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). signs and symptoms of hypersensitivity reactions may occur . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that have been frozen . do this after the capsules have been opened . do away with any capsules you notice
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparze is a white , opaque , hard capsule imprinted with " olaparatib 50 mg " and " astrazeneca logo " on one side . lynparanza is available in packs containing 112 hard
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children . opioid overdose is fatal in adults who have been treated for 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should be aware that opioids may be present in the blood and you should immediately contact your doctor or emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor , pharmacist or nurse before using nyxoids . if you have any further questions on the use of this product , ask your doctor or pharmacist . warnings and precautions talk to your doctor before using this nasal spray , and 2 to 3 hours after using a new nasal spray . this medicine is not recommended for use in patients who are physically dependent on opioids . opioids are often taken together with heroin , methadone , fentanyl , bu
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum or ear . fingernail . 2 . clear the mouth and nose of any blockages . 3 . breathe in through the mouth or nose . 4 . breathe out through the nose . 5 . if breathing is the chest moving , you should hear breathing sounds and breath on the cheek . overdose may occur if you have a response to touch or sounds , slow uneven breathing , breathing , snoring , gasping , gul
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms , which may be more common in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). - the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxax is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxid is available in a carton containing 2 nasal
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries . it is involved for the production of sperm and in the development of a immature egg cell . ovaleaps is used in adult women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who have not undergone assisted reproductive technology procedures ( procedures that help you to become pregnant
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you may have large ovaries or sacs of fluids in your ovaries ( ovarian cysts ). if unexplained vaginal bleeding . if you know you have cancer in your ovarian , womb or breasts . if any condition that makes normal pregnancy impossible such as ovarian failure ( early menopause ). if any of these apply to you , tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medicinal product is for injection under the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you should use this medication every day for the first 7 days of your menstrual cycle . the medicine should be injected every day . this medicine is given in two strengths : 75 mg and 150 mg . you should inject this medicine every day , for 7 days , at least 14 days apart . your doctor will check your response to the medicine . the recommended dose of this
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) type of reaction may occur after your ovaleop injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . do this medicine if it is accidentally frozen . if it has been frozen for more than 3 days , it must be stored at room temperature ( not above 25 ). do this if you notice that the solution is not clear or has particles in it . if the
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection each cartridge contains 300 iiu ( 22 micrograms ) follitruin ala in 0 . 05 ml solution . ovalesap 450 iu per 0 . 75 ml solution : each cartridge produces 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0. 75 ml . ovalap 900 iu/ 1 . 5ml solution for injections each cartridge releases 900 iiu of 66 microgram of follitroin alga in 1
voriconazole accord contains the active substance voriconazol . voronazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( abnormally low white blood cells count ) to prevent candida esp . infections . to reduce the amount of the
do not take voriconazole accord - if you are allergic to vorinazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used used to prevent tuberculosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose will be adjusted by your doctor as follows : 400 mg once daily for 12 hours . this is increased to 200 mg once every 12 hours for 24 24 hours and to 200mg once every 100 hours after the start of treatment . your daily dose will then be adjusted to 300 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor immediately : rash , jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual ac
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). each voricle of voricoazole accord 50 mg film - coated tablets contains 200 mg vorbiconazose ( as mesilate ) the other ingredients of vorbicle of the 200 mg film are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactosemonohydrate and triacetin
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who have been exposed to ebola virus , mvabeas is a 2 - dose course of vaccinations . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine contains the whole ebolairus , which gives you ebola viral disease . warnings and precautions talk to your doctor or nurse before you are given mvabdeno vaccine . you should not receive mvabaa if you have been previously vaccinated with ebola .
follow carefully all instructions given to you by your doctor or nurse . they will explain to you how to complete the vaccination course . if you have not been given the vaccine before , you should not receive it . if your doctor has told you that you have a severe allergic reaction ( see section 6 . if this applies to you , tell your doctor straight away ). if you think you have had a severe allergy reaction , tell the doctor straightaway . if the doctor has given you an antibiotic called ' gentamicin ', you should never receive the vaccine . warnings and precautions talk to your doctor , pharmacist or nurse before you are given m
the dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the recommended dose is one dose of one dose ( 0 . 5 ml ) of vaccine . if you are given zabdeno vaccine 8 weeks later , your doctor will give you mvabea vaccine . the second vaccine will be given at least one month after the first . if your doctor thinks that the effect of the first vaccine is too weak , he or she will give your second dose at least 8 months after the second . if the first vaccination with zab deno
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where thejection is given generalised itching . the most common side effects are : common ( will affect up in every 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( antigen ) 108 produced in chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronAT may also be used if you have a raised calcium level in your blood due to a tumour . this means that calcium is lost from your bones . this helps to stop your bones getting weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - if there are low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you have a possible side effect called osteonecrosis of the jaw ( onj ), which can be caused by bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj can be life - threatening and can be fatal . stopping treatment with on
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide how much bondronat you need and how often you need to have it . patients with cancer the recommended dose is one infusion ( drip ) into your vein once a day . your dose may be adjusted . your physician will carry out regular blood tests while you are using bondronAT . your response to this medicine will depend on your illness . patients having breast cancer that has spread to the bones the recommended starting dose is 3 mg every 3 - 4 weeks . your next dose will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in up to1 in 10 , 000people ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . do this medicine if it is accidentally frozen . do throw away any medicines via wastewater or household waste . ask your pharmacist how to
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . it is supplied in a glass vial containing 1 ml or 2 ml of solution , with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is given to adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting ms is due to attacks on the nerve cells . the symptoms usually disappear within a few days or weeks . however , some problems may remain for a few months or years
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are irregular or abnormal heartbeaters ( arrrhythmia ). if any of these apply to you , tell your doctor before treatment is started . if any other reason applies to you ( or you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate and will prescribe you a ' treatment initiation pack ' which is available in your country . the initiation pack is available for patients with a lower dose . the first 4 doses are 0 . 23 mg ozanimod per day . the second 1 dose is 0 . 4 mg ozamanod per week . the third 4 doses ( 3 doses ) are 0. 46 mg ozmod per night .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). other
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains only 0 . 46 mg ozimod ( as hydration ). ozanimode ( ashydrous ) is available in each capsule . ziposia 0 , 92 mg : the active substances are 0 . 92 mg ozmod (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , crosc
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromine and vilterol belong to agroup of medicines known as bronchodilators . what temybrexta is used for temymbric elliptoe is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte : - asthma . temyboric elliptoe should not be used in patients with asthma . - heart problems . - high blood pressure . - liver problems . if you have tuberculosis ( tb ) of the lung . - any long standing or untreated infections . - an eye problem called narrow
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybubric elliptoe may include
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis ) if
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umelidinIUM bromate and 55 microgram s of umclidinicium ( as 22 microgram adsorbed on vilansterol ) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . warnings and risks talk to the doctor or nurse before taking any of this : if you suffer from kidney
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many capsules to take . the recommended dose is one 600 mg capsule once a week for 8 weeks . some infections may be serious and your doctor may decide to reduce your dose to one 600mg capsule once every 8 weeks or to one 12 mg capsule twice a week . zin foro is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg once every 120 weeks . your physician may decide that an increased dose is needed . duration of treatment your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to stop it altogether . medicines to slow bowel movement may affect the number of red blood cells . this may affect up to 1 in 10 people . your healthcare professional
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinFORo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . zinfforo is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer : if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaberalin psfizer . some patients taking pregaabalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase the occurrence
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregabialin pfeizer . you should take pregagalin pfingizer once in the morning and once inthe evening . if you weigh 59 kg or more , you should continue taking pregafalin psfizer once a morning
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregaboralin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregibalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical in the body which is important for movement . it is important that everyone has a functioning brain , and is used to treat parkinson ' s disease . xadago helps to control parkinson ', a condition characterised by sudden swings in the ability of people to move . this makes it easier for people to do normal daily activities , such as walking , to do activities that normally would not be possible for people with parkinson '. xadadago can be used alone or in
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed any of these medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine . these are all used in treatment for parkinson ' s disease and depression . - pethidine ( a strong pain killer ). if you have had problems with your retina ( sensitive
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you the dose to take . if you have moderately reduced liver function , the dose should not exceed 50 mg twice a day , but your doctor may prescribe a lower dose . if necessary , your doctor can prescribe a higher dose . take xadadago with food . xadagon should be taken with or without a meal . if taking more xad
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( see section 2 ). signs include confusion , sweating , muscle rigidity , hyperthermia ( increase level of enzyme creatine kinase in your blood ), serotonin syndrome ( confusion , hypertension , muscle stiffness , hallucinations and hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines for parkinson '. common ( may affect up
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are marked with " 50 " on
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer in adult men whose body does not produce enough testosterone to control prostate cancer . zytiga can be used either alone or in combination with another medicine that lowers testosterone ( androgen deprivation therapy ). zytigo is used in adult women whose disease has not responded to hormone therapy or is not suitable for a treatment that lowers testosterone ( androgens depriving therapy ). it is used together with another medication called prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigiga if : you have severe liver damage or prostate cancer . this medicine has been shown to increase the effects of this type of cancer . your doctor may decide to reduce the dose of this medication . you have liver problems such as high blood pressure or heart failure . you drink a lot of fluid ( either from a well - being or from a household waste ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . you can take zytiga with or without food . if you take more zytig than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet with food . you may take zydiga with food or between meals . if more than 2
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may want to increase your dose of potassium . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( especially in the legs ). - low blood potassium ( seen in liver function test ). - high blood pressure . - urinary tract infection . -
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytigra looks like and contents of the pack - zytige tablets are white to off - white , round , 9 . 5 mm in diameter . the tablets are
fiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfÎ± ). tnfiya is used to treat the inflammatory diseases in adults and children
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your or his child has had a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe you a 20 mg tablet when you are ready to take your first dose . your child ' s doctor may decide to increase the dose to a 40 mg dose when you have the first dose or to a 20 or 40 mg tablets when you cannot take them . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults and children from 2 years of age weighing 30 kg or more 40 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 ) after the last hefiya injection : allergic reaction ( e . g . heart failure ) severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - used syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what ritemva is used for ritemvir is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type a of white blood cells
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris warnings and precautions talk to your doctor or pharmacist before taking ritemria if you : have ever had or might now have a
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to reduce your dose or stop giving you this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritema administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will first be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each ml concentrate contains 10 mg of the active ingredient ritudimab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitafine tella is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be
do not take capecitabine teva if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) if you can become pregnant if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if any of these apply to you , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . this is given as one tablet of 150 mg / day . this dose is given if you weigh 64 kg or more and your height
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhoehoea at night , vomiting or vomit ( nausea ) and / or lose your appetite . stomatitis : if your doctor thinks you may have pain , redness , swelling or sores in your mouth and /or throat . hand and foot skin - reaction : if the doctor thinks that you
what capecitabine teva contains the active substance is capecitabiline . capecitavine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitaboline . the other ingredients are : capecitafine tella 500 mg film film - coat tablets each tablet contains 500 mg capecabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosic recordati is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is indicated for the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is going to undergo eye surgery - if the doctor has noticed cloudiness of the lens in the eye during cataract surgery 26 - if any of these apply to your child , tell your doctor . silodocin recordat may be used alone or in combination with other medicines if your baby has a loss of muscle tone in the iris (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule taken once a day , with or without food . the maximum recommended dose is 8 capsules taken once daily . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodnosin recordat is taken once every day , at about the same time each day . you should take the capsule at about 4 times a day . if taking silodousin recordata at the same
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , tell your doctor . the symptoms may include dizziness and faints . if any of the above occur , tell the doctor or pharmacist . if necessary , stop taking silodnosin recordi and seek medical advice straight away . complications following a catar
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodusin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : each capsule contain 4 mg siliodosin . as well as mannola , magnesiumstearate, sodium lurilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosiin recordi looks like and contents of
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems ( such as cholestasis or biliary obstruction ) which are problems with drainage of the bile from the liver and gall bladder . - tell the doctor if any of these apply to you . - if your doctor has told you that you have any other severe liver disease . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to crush or chew the tablet . if you take more kinzdalmono than you should if you have taken more tablets than you have been told to , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects : uncommon ( may affects up to one in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this by the time you take your kinzalmono tablet , but do not remove the tablet from the blister . do away with the blister and write the date you first opened it on the blister to indicate that you have taken it out of its refrigerator .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzallmono is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology . the active ingredient in afstylfa is lonoctocog alfa . afstlinga is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor v ii is involved in blood clotting and is necessary to clot the blood . patients with an increased tendency to bleed have been shown to have a higher level of factor v viii in their blood than in patients of all ages . afostyla does not contain any other ingredients
do not use afstyla if you have had an allergic reaction to afstila or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstla . the dose and the batch number should be recorded in your treatment diary . do not use more afstlva than your doctor has recommended . allergic ( hypersensitivity ) reactions are rare in patients receiving afststylfa . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the severity of treatment you have , the severity and location of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be mixed before use to avoid aseptic conditions . afstlva may be used with other medicines or solvents . see section 6 . the
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding from previous treatment with factor viii medicines ( inhibitor antibodies ) ( see section 2 ) very common ( may affect more than 1 in 10 people ) patients who have received previous treatment containing factor v iii ( more than 150 days of treatment ) uncommon ( may effect up to 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture . the recon
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog aluminium . after reconstitution with 2 . 25 mg lonoCTocog aluminum , each vials contains 200 iu lonoactocog alpha . each 1000 iu vial provides 20 ml of solution . after initial reconstation with 2. 5 mg loroctocag alfa , each 400 iu / ml vial delivers 20 ml lonoxtocog Î± . each 1500 iu or ml vials provide 20
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidly trap dabigATran . what it is done with prax Bind is used when pradxa is not being used in patients who are undergoing emergency surgery or who need urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine . serious adverse reactions have been reported with the use of this type of medicine in patients taking dabigatran . other medicines may increase the risk of blood clots . dabigATran is another medicine that is absorbed into the body and may increase your risk of getting blood cl clots
the recommended dose is 5 mg / kg body weight ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a day . you will be monitored for the development of blood clot formation during your treatment with dabigadran . you should be monitored during your first 5 days of treatment with this medicine . this medicine should never be given into a vein . if you have any further questions on the use of this medicine , ask your doctor or nurse . your doctor will decide on the appropriate dose . your treatment will be overseen by a doctor experienced in the diagnosis and prevention of blood clot formation .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then alone ( monotherapy phase oftreatment ). - in children 3 years of age and older and adult patients with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if any of these apply to you , tell your doctor . if you notice any of your blood cells are severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may prescribe other medicines ( anti - emetics ) to help you take temomeda to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy ( concom
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( fits or convulsions ), fever , chills and severe headache , stop temomedac treatment and seek medical advice immediately . a reduction in certain kinds of blood cells ( increased bruising or bleeding ), anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections may occur . the reduction in blood cell counts is usually temporary and can be life - threatening . if this happens , you may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolsomide ( as mesolomides ). temomedoc 20 mg :each capsule contains 20 mg tem ozolomine ( as temolomix ). temmedac 100 mg : one capsule contains 100 mg temzolomid ( as Mesolomises ). temormac 140 mg : two capsules contain 140 mg temosolomile ( as besilomide ). temarmac 180 mg : three capsules contain 180 mg temizolomage ( as
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual performance . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax , allowing blood to flow into your penis . this helps to maintain erectile function . ceralis is used to treat adult men who do not have erectile disease . civalis
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you : - if this applies to you , tell your doctor straight away .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg per day . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if not , show it to your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain . these may occur more often in men taking nitrates ( frequency not unknown ). priapsim may cause a prolonged and possibly painful erection . if you are taking cialis , you may find that you do not get an erection until at least 4 hours after taking it . contact your doctor immediately if you experience sudden loss of vision ( frequency unknown ). other side effects very common ( may affect more than 1 in 10 people ) uncommon (
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when you start taking enygalid on its own or with metformin . if you have diabetes , en
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your physician has told your doctor that you suffer from liver problems . if any doctor has advised you that your doctor needs to adjust
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once a morning . your doctor may increase your dose to 4 mg once daily . your daily dose may be increased to 30 mg ( once a daily ) once a week for 16 weeks . your blood sugar may be lowered if you take enysglid more often than you should . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up to one in 10 users ): stomach pain diarrhoe
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet and red iron oxide (< e172 ). only in 2 mg tablet . what eny glid looks like and contents of the pack eny Glid
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myla is used for azacinidine mylon is used to treat adults . what it is usedfor azacuitidine myan is used in adults . azacididine mylin is used after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also be used in children with acute myeloid
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacnitidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition ( such as heart attack ). - tell the doctor if you have lung disease
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl to give you . your dose of this medicine will depend on your height and weight . azacacitine mylan will be administered every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( sub - subcutaneous ) such as the thigh , tummy or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may all be symptoms or signs of kidney failure , which might be a fever , which could be a sign of an infection , which can be life -
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine will be stored by the health professionals at the hospital or clinic . the suspension must be used within 1 hour after preparation . the azacidine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). do not freeze . the zacitine mylan suspension must either be stored at room temperature or kept refrigerated ( 2 - 8 ). if the suspension is stored in
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg azacita . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol . what azacididine myl looks like and contents of the pack azacitonidine mylon is a white powder supplied in a glass vial containing 100 mg of azacacitine . pack sizes of 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timololed is a beta blocker that reduces fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye due to an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ). - warnings and precautions talk to your doctor or pharmacist before taking duotra : - if the child has ever had heart failure ( a disorder of heart rhythm , irregular heartbeat ),
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in each eye once a day . do not use duotrav in both eyes . use duetrav in the eyes only . how to use duofrav is for oral use . use it as instructed by your doctor . how long to use it depends on how much you weigh and how often you use it . how often to use use duoprav in your eyes : - the recommended daily dose is 1 drop in the affected eye each day . -
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be swallowed whole with water . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects on how the eye surface inflammation or surface damage is caused by eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms of eye irritation such as burning or stinging . uncommon side effects : ( may affects up to1 in 100 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg travaprost and 5 mg timolole ( as timololed maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . what duotra looks like and contents of the pack duotrave is a liquid ( a clear ,
nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in patients with a type of immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in keeping blood clots free of blood . very low platelets can lead to bruising and serious bleeding . nplate is used to treat adults and children aged 1 year and older with spleen removed or chronic itp who have previously received corticosteroids or
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ) if you take n plate , your platelet counts may increase . this is linked to the increased risk of blood clots . if you suffer from blood clotting , you should tell your doctor . if any of these apply to you , tell your physician . if
nplate is given to adults and adolescents ( aged 1 to 17 years ) who are able to take nplate . how nplate is administered nplate will be given as an injection under the skin ( subcutaneous ). it is given at least 1 hour before or one hour after taking nplate , depending on your platelet counts . your doctor will take regular blood samples to check your platelets and your plate clot count . the amount of nplate in your blood will be calculated by your doctor . your platelett count will be checked at least every 1 hour during treatment with nplate and at least once every 17 hours during treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ), a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial of 125 mg contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial contains 125mg romiplustim in the deliverable amounts . each two - dose ampoule of 500 mg contains 375 mg romclostim and 250 mg romphostim each single dose ampuele of 625 mg contains 250 mg . each three - dose ephedrine of 500mg romplust
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the amount of air that gets in and around the lungs when you breathe . this is important
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma - tell him if you experience difficulty passing urine during treatment with tovannor breezer . if you think any of these apply to you , tell your physician or pharmace
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you should inhale this medicine every 24 hours at about the same time each day . the recommended starting dose is one 75 - day inhalation dose . you can use this this medicine at any time of the day , with or without food . how to use this medicinal product comes as an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation powder .
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide and 50 microgramms glycopyronium . each delivered dose ( the delivered dose ) leaves the mouthpiece of the inhaler with approximately 44 microgram of glycopYRronium per inhale . - the other ingredients of the inhale powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microlitre inhal
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the most common symptoms of bipolar disorder
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvo ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuva if you have symptoms such as wheezing , shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath . these may be signs of 25 neuroleptic malignant syndrome ( nms ), a group of symptoms that have been reported in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 weeks ) and 4 . 5 mg twice daily . your doctor may adjust your dose depending on your condition . adasuve is for oral use . it should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or break the tablet . if you use more adasuva than you should if you accidentally use more tablets than you have been told to , contact your doctor immediately . if possible , show the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , which may become irritating and difficult to breathe . these may be signs of problems with your airways ( asthma or copd ). - light - headedness or fainting . these could be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 mg of loxapeine . - each single dose delivers 4 . 5 mg loxide . what adasuves looks like and contents of the pack adasuva 4 . 95 mg is a white to off - white plastic inhaler , with " lox " printed on the cap and " adasu " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuved is available in packs containing 4 .5 , 1 or 5 inhalers . not all pack sizes
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called cytokines . what azaccitidine betafarm is used for azaciticidine betaparm is intended for use in adults . azacituidine betagarm is given to adults who have not had a stem cell transplantation . it is used in : - to treat higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute myeloid leukaemic
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix betapham . - if the patient has decreased counts of platelets , red or white blood cells . - tell your doctor if you have kidney disease . - your doctor may tell you if you suffer from liver disease . if you know that you suffer or have ever suffered from a heart condition ( such
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine betabarm you need . your dose of this medicine will depend on your height and weight . azacididine betafarm will be administered every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( sub - subcutaneous ) such as the thigh , tummy
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure , which might be a fever , which could be signs of an infection , which can be fatal in some
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they will take care of you and dispose of any unused azaccitidine betabarm correctly . this medicine is for single use only . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the azacnitidine betafarm suspension is for injection and is for use in single use .
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacitasidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacituidine betabarm looks like and contents of the pack azacididine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacritidine .
ceberdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucosolceramide , it can cause your affected organs to relax . your doctor will test for this before you start taking this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if your doctor
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is taking moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take depends on the type of metabolizer you are taking . the usual dose is two tablets twice a morning , one tablet once a day . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets once a morning . swallow your tablets with one glass of milk . do not divide , crush or chew the tablets . if you take more cerdelga than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack
the active substance in zoledronic acid hospira is zoledor acid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult people when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiral if any of the following apply to you : if you have a kidney problem . if you experience pain , swelling or
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . this is in case of dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may lower the dose depending on your kidney problem . how often zoledron acid hospir is given your doctor will decide if you should be given a higher dose . if your doctor determines that your dose is too low , you may be at increased risk of bone complications ( e . g .
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( may be determined by your doctor with certain blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge , numbness or a feeling of heaviness or loosening of a tooth ) bone damage in the jaw ( osteonecrosis ). if you experience
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledrin acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight cancer . they help your body to make its own medicine . varuby works by blocking the nerve cells in your brain that produce the medicine . this helps to prevent vomiting and being sick . rolapitit works by stopping these nerve cell cells from producing the medicine that causes nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking varubry if you : have depression or difficulty sleeping ( see section 2 " warnings and risks "). have ever taken this medicine 27 have severe liver or kidney problems . have ever been treated with certain medicines ( e . g . rifampicin ). have ever had tuberculosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablet at least 2 hours before your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you have been told to , contact your doctor straight away . if possible , show them the pack . if sickness
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and take appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache constipation feeling tired uncommon ( may effect up to1 in 100 people ): sore
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapitin . - the other ingredients are lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry is
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone furate belongs to agroup of medicines known as corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes or high blood sugar if you experience seizures if you develop severe kidney problems if any of these apply to you , tell your doctor .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . the medicine should be inhaled once a week . use enerzair breezhaler every day , at the same time of the day . this will help control your asthma and reduce your symptoms . use only enerz air breez inhaler once a month . how to use enerzeair breezehaler is for inhalation use . you will find an inhaler and capsules that contain the medicine in the inhaler . the inhalers are
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side side effects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacataterol as acetates , 63 microgram of glycopirronium bromides , 50 microgram glycopierronium , 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram ( 0 . 5 ml ) of indiacaterol (" as acet
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events , which can lead
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel agababil ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmara gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel apharma gmbhl per day to be taken orally with or without food . you can take cloclopidigrel acine pharma h with or just after food . if you take more clopidoogrel agrogrogrogh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 100 ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems such as
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrel aclarica gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmÃ¡ gmb h looks like and contents of the pack clopidiogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( also known as a nucleosiderase analogue reverse transcriptases inhibitor ( rrti ). the other active substances in delstrigo are tenofovir disoproxil ( also called a nucleositide analogue reverse transcriptase inhibitor , nrti ) and lamivir
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if taking any of them , tell the doctor or nurse that you are taking any or all of the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ), phenytoin ( medicines used to prevent seizure ), rifampicin and rifapentine ( medicine to treat asthma
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . your doctor may prescribe you certain medicines ( such as doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more delstriga than you should if you have accidentally taken too many
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material containing carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is also used in children and adolescents ( aged 2 years and older ). there are many different types of antidepressant medicines .
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can occur . serious complications in these conditions can occur , and spravo should be stopped immediately . tell your doctor before taking this medicine if you have a heart problem such as poor blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is a clear , colourless liquid . the nasal spray device is contained in a separate sachet . you can use it with or without food . the recommended dose is 1 spray , 2 spray devices , 3 nasal spray devices and one nasal spray handset . use within 4 hours of the time you usually use spravata . use in children and adolescents spravat is not recommended for children and teenagers under 2 years of age . use this product
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to noise in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious in the eyes or ears feeling like your sense of touch are deceived or mimicked irritable panic attacks change in perception 37
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravatos looks like and contents of the pack spravat is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in packs containing one single - use nasal spray handset . spreamato is available as packs containing 1 , 2 , 3 or 6 nasal
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene responsible for producing melanoma cells . zelborab targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if allergic reactions occur during treatment with zeloraf , tell the doctor or nurse immediately . if you have any symptoms of an allergic reaction , such as swelling ofthe face , lip
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 capsules taken once a day for 8 days . your doctor may increase your dose to 4 capsules once a week if you experience side effects . your treatment with zelboraf may be stopped if you suffer from vomiting . take zelbaf once a morning . take the capsules with food . zelbaraf should be taken on an empty stomach . swallow the capsules whole with a glass of water . do not crush or chew the capsules . if you take more zelberaf
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelbaf and tell your doctor immediately if you notice any of the following : radiation treatment tell your nuclear medicine doctor immediately : if you get any of these symptoms , including skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been treated with other products called non - steroidal anti - inflammatory products . if your doctor has told you that you have painful and / or inflammatory conditions of muscles or joints . if this applies to you , tell your doctor . if any of these apply to you . if the patient has a medical condition ( e . g . asthma
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , contact your doctor at the nearest hospital emergency department immediately . the risk of bleeding is not known . if more than one tablet is taken at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid (asa ), 75 mg of clopridogrel and hydrogen sulphate ). the other ingredients are : 75 mg acetyl salicylic acids ( as mannitol , macrogol 6000 ), microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists . it works by reducing pressure within the eye . simbrinz is used in the eyes of adult patients ( aged 18 years and older ) to treat eye conditions such as glaucoma , ocular hypertension ( high pressure on the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) if any of these apply to you , tell your doctor before taking simbranza . if you have been taking diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if you take certain antidepressants . if any antidepressant medicines have been taken with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly after using simbrine ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . hold the medicine with your fingers . before using the bottle , twist off the cap . pull down your thumb and fingers . tilt your head back . pull back your eyelid with a clean finger until there is a ' pocket ' between the eyelid
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : common side effects ( may affect up to 1 in 10 people ) effects affecting the eye ( allergic conjunctiv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of the brimonididine tartration equivalent to 1 . 3 mg of Brimonidine ). the other ingredients are benzalkonium chloride ( see section 2 " simbrinnza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water ,
what filgrastim ratiopharm is filgrastaim ratisopharm contains the active substance filgrasterim . filgrasteim is a protein produced by biotechnology in the laboratory of escherichia coli . it is a natural protein produced in the body by biotechnologists called granulocyte - colony stimulating factor ( gsf ). filgrateim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . what filgratim ratinopharm does filgrustim ratim rat
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm if you have ever had a cough , fever or difficulty breathing . this may be a sign of a pulmonary disorder . tell your doctor straight away if you get any of these side effects : sickle cell disease 57 left upper abdominal pain or pain at the tip of your shoulder ( this may indicate a spleen disorder ). your doctor
how much filgrastim ratiopharm is given the amount of filgrasterim ratisopharm you will receive will depend on your condition and on how well you respond to filgrastaim ratitopharm treatment . filgrasteim ratiotopharm will be given to you in two different stages : chemotherapy : the usual dose is 0 . 5 mg per kilogram body weight once daily for 60 days . you will be treated for 30 days . your treatment will last for 14 days . some disease types may be more severe . filbrastim ratiopharm should be given after bone marrow transplant
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 you should tell your doctor if you get left upper abdominal pain or pain at the tip of your shoulder ( this may be a symptom of a spleen disorder ). see section 4 . if you experience any of the following side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are a type in your blood . they are important in helping your body to fight infection and to help your body adapt to treatment . other medicines
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrasim . filgraspim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastime in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg of the active ingredient filgrgrastrim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial ac
what riluzole zentiva is riluxole zenta contains rilusole which belongs to a group of substances called cytokines , which are involved in the nervous system . what rilizole zENTiva is used for rilustole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells in the muscles are damaged , leading to weakness , muscle waste and paralysis . the destruction of nerve cells by motor neurones disease may result in too much glutamate ( a chemical messenger ) in the brain and spinal cord . r
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have anyiver problems . yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( these may be signs
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . for adolescents 12 years of age and older , the recommended starting dose is two tablets a day ( one tablet in the morning and one tablet at the evening ). if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if you forget to take rilzole zenta if you miss
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and embossed with ' 50 ' on one side and ' ril ' on the other side . the tablets have a diameter of
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of cgrm . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have at least 4 migraines per month . emigality can be used alone or in combination with other treatments to reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you experience such signs or possible side effects . see section 4 . children and adolescents emgale is not recommended for children and teenagers under 18 years of age . other medicines and emgals tell your doctor or pharmacist if you use , have recently
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given under your skin ( subcutaneous injection ). you may receive your emgalis injection after proper training . if you have been given more emgals than you should if you think you have received more emgsality than you have needed , tell your doctor straight away . if more emmality than your doctor tells you to , tell the doctor or nurse immediately . if possible , your doctor may give you a double dose to make
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the product may be stored for up to 7 days below 30 . do this in the event that you notice that the solution is not clear or contains particles . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumb in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is supplied in single - dose pen packs of 1 , 2 , 3 or a multipack of
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it can be given to you by a doctor or nurse , or by a combination of medicines you have received prior to a stem cell transplantation . defibrobrotide works by helping the blood arteries to open and close , so that the blood clasts can be removed . your doctor has prescribed this medicine for you because you have no other treatment .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if you take medicine to prevent bleeding ( e . g . heavy bleeding , if you need a blood transfusion or surgery ). if your doctor has told you that you have problems with blood circulation or a constant blood pressure . warnings and measures talk to your doctor or pharmacist before using defitilio . children and adolescents this medicine is not recommended for use
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . your doctor will decide how much defitlio you need and how often you need to receive this treatment . the recommended dose is 21 mg once a day . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce your dose . if you have any further questions on the use or use of this medicine , ask your doctor or pharmacist . children and adolescents
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and talk to a doctor or go to the nearest hospital straight away if you notice any of the following side effects : these side effects may occur with defitlio : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine in the mouth bleeding from under the skin coagulopathy
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not give defitilio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as an add - on to the solvent ). each ml solution provides 80 mg of the active substances in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - tablets containing a medicine called quinidine . this helps to reduce the amount the virus can in yourblood . dakinza may be used in addition to other medicines used to treat
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with any of your following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) dexamethasone , a steroid ( used for allergic and inflammatory diseases ) medicines called st . john ' s wort (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklanza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , show them the pack of these medicines . your daily dose of taklin
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dakinza in tandem with sofuosbuir and ribvirin has also been associated . very common side effects ( may affects more than1 in every 1 people
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) ( only in 51 mg film - coating ). what dakline
proquad is a vaccine to protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s natural defences ( antibodies ) make the measles , rubles , rubellia and varicellis viruses less effective . when the antibodies make these antibodies , diseases can occur . these viruses are called cytokines and live viruses . proquad is intended for individuals who have measles , come from a family of live viruses , such as measles , comes from a close relative , or from a relative who has rubella or chickenpox . the vaccine is recommended
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have been given neomycin if you suffer from a blood disorder or type of cancer that affects the immune system ( treatment with medications that weaken the immunesystem ) if your doctor has recommended low - dose corticosteroid therapy ( for asthma or replacement therapy ) if any of these apply to you , tell your doctor . if you currently have a weakened immune system , a disease ( including aids ), congenital or hereditary immun
proquad is given by injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections may be given into the muscle ( usually the thigh area or upper upper arm ) as directed by your doctor . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the same skin may increase the risk of bleeding and therefore proquad should not go into a blood vessel . proquad is injected into a vein . pro quad is given as an injection into the skin . adults and adolescents from 9 years of age and older
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may have difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side side effects reported with the use of proquad are :
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , 4 . 30 mg rubella virus2 , strain , 6 . 00mg varicella virus3 , merck strain , 9 . 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , neomycin
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the inflammatory effect jylamv is used to treat rheumatic and skin diseases : - active rheumatoid arthritis ( with polyarthritic forms in the joints ) - severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it can be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) or together with inadequate o severe and disabling psoriasis . it
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an inflammation
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . jylamvo can be used for any condition , and may cause severe side effects , sometimes even death . your doctor will determine the dose you need and will adjust the dose depending on the response to the treatment . rheumatoid arthritis , severe juvenile idiopathic arthritis , or severe psoriasis . if you have severe psoriatic arthritis , your doctor may recommend jylimvo as a long - term treatment . jjlamvo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . after reconstitution , the product should be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotreate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydroxybenzoates "), citric acids , tri , sodium citrates ,
what enurev breezhaler is this medicine contains a substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help adults and children with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if there is an eye problem called narrow - angle glaucoma . - tell your doctor if you have difficulty passing urine . treatment with enurevo breez inhaler should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enurevi breezer . these may be signs of bronch
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at a temperature not above 75 . you can use this product at any time of the day , with or without food . do not take this medicine if you notice that the capsules are not clear or have particles in them . how to use this medicinal product comes as an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation powder . the capsules should be swallowed whole with water .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing , swallowing , dizziness . allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , tell your doctor . some possible side effects ( frequency not known ) are listed below . other possible side
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycoprroniumbromide , equivalent to 50 microgram glycopyronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is 44 microgram of glycopYRronium per inhale . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre inhal
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . riximyo is used for the treatment of several different conditions . ruximyo can be used in adults with : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . it affects the immune system ( the body ' s
do not use riximyo : - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection at the moment . - if the child has had a weak immune system . - tell your doctor if the patient has severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using riximusyo : if your baby has granulomatosis , polyangiitis , microscopic polyangiaitis or p
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose you need and will decide if you need to be treated again . if you experience any side effects during your treatment with rixamyo , your doctor may give you other medicines ( premedication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . if necessary , your treatment may be stopped . if your doctor determines that you have
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack rixIMyo is a clear to slightly yellowish solution for infusion . it is supplied in
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat adults with small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be treated by surgery or radiotherapy . in this case topotan actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your doctor may check your blood cell counts if they are too low . your dose of topotican actv may need to be adjusted . - if your doctor has told you that you have any kidney problems . your treatment with topotnican actez should be carefully supervised . warnings and risks talk to the doctor or nurse before using this medicine if any of
your doctor will determine the dose of topotecan actavis you will receive and will determine how much you will be given based on the results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for every square metre you weigh , for every 5 square metre that you weigh . this treatment cycle will also include a dose of cervical cancer of 0 . 75 mg per sq metre of surface area , for each square metre which you weigh each day , for at least 3 weeks . thistreatment cycle will only be started if you are being
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . your doctor may need to adjust your dose . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may affects up to 1 in 1 , 000 people ): difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability refers to the last day of that month . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 Â± 2 and from 2 to 8 when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose 5 %
what topotecan actavis contains the active substance is topotan . each vial contains 1 mg or 4 mg topotecaan ( as hydrochloride ). after reconstitution , 1 ml of solution contains 1mg of topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotecoan actis looks like and contents of the pack topottecan activ is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , with a
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivastaigmine ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your medicines : - if any patient has
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also adjust your dose depending on your weight . taking this medicine if you have not taken rivaldigminehexal for more than three days , do not take the next dose until you have talked to your doctor . taking the next
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may effect up to1 in every 100
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each rrivastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each rivanast
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be used alone or in combination with a specific anticancer medicine containing sorafenib . what cabometyx does cabometx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ). these proteins are involved in the development of high amounts in cancer cells . cabometometyx can be prescribed to you by your doctor or nurse .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : - if your doctor has told you that you have high blood pressure - if the patient has an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if there is diarrhoea - if a recent occurrence of significant bleeding - if surgery has taken place within the last month - if any of these apply to you - if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on how you respond to your treatment . this will help reduce the risk of serious side effects . your treatment will be started by a doctor who is experienced in the treatment of patients with dementia . the usual starting dose of cabometyx is 60 mg once a week . you can take cabometometyx with or without food . you may take cabostyx for
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx : you may be given other medicines to treat your side effects . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine that may lead to severe or uncontrollable bleeding ). symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains caboxantinab . cabobometyx 40 mg : every tablet contains Cabozanthinib (s ) and Malate . each dose of 40 mg contains Caboxantineib . cabostyx 60 mg : one tablet contains cabozantanib ( sin ) and / or malate , and each tablet delivers 60 mg of cabozantsinib . the other ingredients are
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemdesed hospir will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if pemetreed hospiera is suitable for you if you have lung cancer at an advanced
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetroed hospiar , your doctor will check before each infusion that your blood is being
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will use this body surface area to work in exactly the right way for you . your dose and duration of treatment will depend on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospire will be given to your doctor by
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash , burning or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2Âºc - 8Âºc . the reconstitution solution should be used immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be disposed of .
what pemetrexed hospira contains the active substance is pemetre . pemetresed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetemetrexes hospira 500 mg : one vial of 500 mg contains 500 mg ofpemetrexereed as petrexeddisodium hemispentahhydrate . pemrexedospira 1 , 000 mg : the active ingredient is pemphigus . each vials of 1 ,000 mg contains pemetretted
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timololine belongs to medicines called beta - blockers . ganfort is used to lower pressure in your eye . it is used in adults , adolescents and children aged one month and older . it can be used in adult patients whose eye is a clear , watery liquid . gansfort is also used in children aged two months and older who have gl
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol or beta - blockers ( see section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if they have long - standing cough - if his / her child has heart problems - if their child has low heart rate - if there is a risk of heart block or heart failure warnings and precautions talk to your doctor or pharmacist before using this medicine - if any
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the carton . - do not put ganf into your neck . 5 . gently squeeze the bottle . 1 . wash your hands . - tilt your head back . 2 . pull down your eyelid , which is causing a small pocket to form . 3 . gently press down on your eye during treatment . 4 . gently pull down the lid of your eye . 5. gently squeeze your eye with a finger . - close the eye lid on your nose .
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects when taken with ganart ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . ganf is stable for up to 4 hours at room temperature . do this as long as your doctor continues to prescribe it . do you notice that the solution is not clear or contains particles ? do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each bottle contains 5 mg of timolov maleate in 6 . 8 ml . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , colourless to pale yellow eye drop drop drop drops in a
gefitinib mylan contains the active substance gefitinib . this protein stops the growth of cancer cells . gefinib melan is used to treat non - small cell lung cancer in adults . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinib melan . if you have any other lung problems . some lung problems may be serious . gefinib yourlan may cause problems with your liver . talk to a doctor , nurse or pharmacist before taking this medicine . gifitin ib mylan is not recommended for use in children and adolescents under 18 years of age . other medicines and g
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take gefnitinib melan with food that you have trouble swallowing . if you take more antacid than you should if you accidentally take too many tablets , contact your doctor . if possible , take your tablets with food and drink . do not open or crush the tablets . gefitonin
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood infusion . reblozey is used in adults to treat anaemia in adults with mds who cannot be treated with red bloodcell therapies ( erythropoietin therapies ) such as beta - thalassaemia . thalAss
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and you are not taking preventive measures ( e . g . medicines to prevent a blood clot ) if your doctor determines that you have high blood pressure . your dose of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the dose depends on how much you weigh . the injections should be given in a maximum of 1 . 0 mg / kg body weight . your dose may be adjusted by your doctor if needed . your blood pressure may be monitored while you are using re blozyl , and your doctor may adjust the dose . in myelodysplastic syndromes the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , with blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 days when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspatingcept . - the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for phase ph adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . reblosyl is supplied in v
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and attaching to new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda . high blood pressure tell your doctor if you have any changes in your blood pressure . your doctor may prescribe a medicine to lower your bloodpressure . fotiva may lower your dose of fotiquda if your blood hypertension is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . fotivda 1340 mg capsules are available in capsules of 21 mg and 7 mg . you will take 1 capsule in each capsule and 4 capsules in each other . fotonivda may be taken with or without food . if you experience unacceptable side effects or severe side effects , stop taking fotvda therapy and contact your doctor . the recommended dose of fotiveda is 890 mg capsules for 21 mg . this 21 mg capsule is available in packs of 7 mg and 1 capsule and
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur commonly in women and men ) see section 2 " warnings and precautions ". tell your doctor immediately if you have high blood blood pressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state ( such as feeling anxious , confused or disorientated ). your doctor may need to adjust your dose of fotivda . high blood hypertension may be treated with a medicine to control your high bloodpressure . if you take more fotvda than you
what fotivda contains the active substance of fotivex is tivozanib . each tablet contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivuzanib , mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide e171 ) in tartrazine aluminium lake ( e133
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine ( an antiiretroviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antipirtrovir medicine called an nucleotide reverse transcriptases inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus (
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disaproxil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have alfuzosin ( used to treat an enlarged prostate gland ), amiodarone , quinidine ( used for irregular heartbeats ),
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . you should take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) which may affect the absorption of stribild . see section 4 for further information . if you forget to take stribil
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hla - b * 5701 gene or by the other ingredients of the hl disease itself . serious side effects tell your doctor immediately :
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabINE and 245 mg tenofvir disopicroxil ( as mesilate ). each tablet contains 300 mg ten ofovirdisoproxel fumarate , equivalent to 136 mg tenor . the other ingredients are : tablet core : croscarmellose sodium , hydro
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyprixa . zypitxa is not recommended for elderly patients with dementia because it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should take zyxa between 5 and 20 mg once a morning . if your symptoms return but do not stop taking zypoxa do not take your zypxa tablets without talking to your doctor first . take your tablets at the same time each day . zzyprexa coated tablets can be taken with or without food . swallow the tablets whole with a glass of water . do not chew or crush them . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do so if you noticed any change to the appearance or the appearance to the pack . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zyprixa tablet strengths are marked with the following symbols : - zypoxa 2 . 3 mg , 2 . 4 mg
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that is made in the bones after the menopause . as oestrogens level drops , bones become thin and fragile . what is osteopORosis ? osteoporsosis is caused by the lack of testosterone and glucoc
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your child , tell them before using it . if they do not , tell the doctor straight away . warnings and symptoms talk to the doctor or nurse before using the product : if your child has a skin infection with symptoms
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . your doctor will decide how much prolia you need and how often you need to receive it . your dose will depend on how well you respond to the treatment . your treatment will be started by a doctor or a nurse . your healthcare professional will show you how to inject prolia . your caregiver will show the doctor how to prepare and inject prolias . you will be
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms may include fever . stop using prolia if you get pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , you may remove the cap from the vials and allow it to reach room temperature ( up to 25 ) prior to use . after the injection , you can store your pre pre -filled syringe at room temperature up to a maximum of 25 and use it within 30 days
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine for adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus . the liver is swollen and inflamed by the virus . ambirax can be given to people who have the virus in their faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity
do not use ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have signs of such an allergic response , tell your doctor . warnings and precautions talk to your doctor or nurse before using any vaccine for hepatitis a or hepatitis b diseases if you get a severe infection with a high temperature . the vaccine should be given at the same time as a minor infection such as a cold . if any of these apply to you , tell the
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , the second injection should be given between 6 and 12 months after the first . if it is more than 12 months since the first injection , you may be given extra doses to make up for future booster dosing . if more than two injections are given at once , you will be monitored for the diseases
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( 4 , 600 microgram ) of hepatitis b surface antigen ( 4 . 20 microgram ). the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly
what bexsero is bex sero is a meningococcal group b vaccine . what bex Sero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are very common in infections ( such as meningitis , inflammation of the brain and spinal cord ) and in sepsis ( blood poisoning ). the vaccine works by helping the body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex sero if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to postpone vaccination until you recover from haemophilia . you have any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizum
your doctor or nurse will give you bexsero at a dose of 5 micrograms in the muscle of the thigh or upper arm . injections will be given at least 2 weeks apart . the first dose will be administered at least 5 days apart . after three injections , the vaccine may be administered with an additional injection ( booster ). the first injection will be made at least 1 month apart . your doctor will decide on the interval between injections . children and adolescents from 2 months of age onwards the intervalbetween injections will not be longer than 2 months . the interval interval between breaths will not exceed 15 days . children from 6 months of
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injected area at the area where the injection is injected . if any of these side effects occur , stop using this vaccine and tell a doctor straightaway . common ( might affect up to 1 in every
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microgene recombinant neoisseria meingitidas group b fhbp fusion protein 2 and 2 and 50 micromole ( mbq ) produced by recombinant dna technology . the other ingredients are : protein 1 : protein 2 : protein 3 : protein 50 microgamma ( mm ) produced in outer membrane v
what nitisinone mdk is nitisinfone is a medicine used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . in this disease your body does not produce enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone works by reducing the amount of tyrosrine in the blood and reducing the harmful substances that can be present in this medicine . tyrosate is a substance that is produced by the body . low tyrosaline can replace phenylalanine (
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k may affect the eyes , especially during nitisinfone treatment . if you get red eyes or if your eyes get darker , tell your doctor immediately . your doctor may recommend an eye examination . if any of these apply to you , tell the doctor or nurse before taking nitisina mdk . if your doctor determines that you have eye problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight , taken orally once a day , taken at least 20 minutes before or at bedtime . in this patient population the dose may be adjusted by your doctor . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store nitisinone mdk in the original package in order to protect from light . once removed from the refrigerator , nitisinusone mdks may be stored for a maximum of 2 weeks at a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what nitisinone mdk contains the active substance is nitisino . nitis inone md k 2 mg : each capsule contains 2 mg nitisine . nitesinone dk 5 mg : one capsule contains 5 mg nisinone . nisinnone mdyk 10 mg : two capsules contain 10 mg nitesine . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze and water for injections . what nitisinnone looks like and contents of the pack nitisinsone mdks capsules are 15 . 7 mm long , hard
what docetaxel accord is docetayel accord contains the active substance docetxel . docetixel belongs to a group of anti - cancer medicines called taxoids . doceteaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer alone , docetailel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . -
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetayel accord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoea , rectal
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken to check your generalcondition . in particular , docetAXel accord should be used
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . do away with the vial and any remaining contents of the vials . after dilution , the medicine should be transferred from the infusion bag to the infusion vial immediately . this is done within 6 hours ( at 25 ). infusion - related storage : the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to 8 . do
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg doceta . each 1 ml of the concentrate contains 20mg docetea . each 4 ml of of concentrate contains 80 mg docnetaxel . every 8 ml of solution for injection contains 160 mg docotaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetagrel accord contains ethanol an hydrous "), citric acid anhydrated ( see " docel accord contain ethanol anhhydrous "). what
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product works by reducing the activity of the nervous system , such as the nervous systems . this helps to stop people becoming impulsive , hyperactive or both . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately responsive to current stimulant medication or whose adhd symptoms are not well controlled . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used in adults 38 years
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunv if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . tell your physician if you know or have any other psychiatric conditions or withdrawal symptoms . increased heart rate and high bloodpressure tell your healthcare provider if you take this medicine at any time during the day or night , as this may increase
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on your response to treatment . the starting dose is 0 . 05 mg / kg bodyweight once daily for the first week . your daily dose will then be gradually lowered to 0 . 12 mg /kg bodyweight twice daily . the first weeks of treatment will then gradually increase to
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should take your medicine and continue to take it as before . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use this medication if you notice that the tablets are damaged or are not clear . blister pack : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each extended - release dose contains 2 mg guinfacine ( see section 2 under ' intunive contains guanfu '). each prolonged prolonged -release tablet contains 3 mg guaconfacine [ see section 3 under ' guanfa hydrochlorides contains 3mg guangin '). every extended -release dose contains 4 mg guanofacine . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copoly
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines prevent serious fungal infections from spreading and destroy the fungal cell walls . ecalta is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , or stop your treatment , if you receive anaesthetics . your treatment with ecaltfa may need to be delayed . if you experience an allergic reaction , such as itching , wheezing , or blotchy skin , tell your doctor
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg or 100 mg given once a week . the dose is 1 dose in the morning ( breakfast ) and 1 dose after dinner ( dinner ) in the evening ( dinner ). adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg . this is given as 200 mg given as 1 . 5 mg per day . the doctor may increase the dose to 100 mg depending on the patient ' s weight . ecalta is given by slow infusion ( a drip into a vein ) over a period of 1 . 4 to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . the infusion solution should preferably be stored at room temperature ( up to 25 ) for up
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). the human coaggulation factor iii is produced by recombinant dna technology . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced . adynovi is used for the treatment and prevention of bleeding in patients 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii
do not use adynovi : if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using adynov : if an anaphylactic reaction ( a severe , sudden allergic reaction ) occurs , stop using adnovi and contact your doctor immediately . allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia . adynov is used for treatment of bleeding . adnovi is used as the replacement therapy for adynocid . adynaovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . dosage and prevention of bleeding the recommended dose of adynova is 40 mg once a day . your doctor may increase your dose to 50 mg once daily for 2 weeks to help prevent bleeding . the dose of adsynovi depends on your body
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath , or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is not used within 3 days or if it has been stored at a room temperature not above 30 for a longer period than 3
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfapegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polys
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries and are responsible for the development of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have : a large tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus , enlarged ovaries or cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( which may be a risk of pregnancy ), fibroids of the uterus ( which can
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will prescribe a type of anti - mÃ¼llerian hormone that stimulates your ovaries to produce stimulation with gonadotropins . the dose will depend on the amount of hormones in your blood . your dose will also be calculated from your body weight . your physician will take a blood sample during the last 12 months to work out the right dose for you . how much rekole you will receive
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that cause infertility have been reported in women taking this medicine . there may be a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms seek medical advice straight away . a side effect may affect up to 1 in 10 people headache nausea ( ovarianhyperstimulation sensation ) pelvic pain or discomfort ( ovarian origin tiredness or fatigue ) uncommonly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product may be stored at room temperatures ( up or down ) for up to a maximum of 3 months in a freezer ( 2 to 28 ) at room room temperature not above 25 . after the end of
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptka contains either fluticasaone fudge 92 mg or vilancerol 22 mg . each inhale of flutic asone fudoate 184 mg or rilanterols 22 mg is equivalent to 92 / 22 mg of the active substances . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . the 184 mg / 22 inhalation dose is the same as for adults . cop
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects in patients who have moderate or severe liver disease , but the lower strength of revintchy ellipta 92 / 22 mg / ml is recommended for these patients . talk to a doctor or nurse before using revintey ellipta if you have
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalant each day ). the recommended strength is fluticasone furoate 22 mg twice a morning ( one tablet each day ), and vilanterol . copd the recommended starting dose for copd is one and a half inhalations twice a daily ( one and only daily ). the higher strength inhaler is flilitasonefuroate 23 mg twice daily ( two tablets each day ,
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , sometimes of the face or mouth ( angioedema ), feeling very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta stop your
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic as a 22 mg dose of vilancerol and trifenatate . each 184 microgramS inhalation provides 184 microlitre of flilitasonefuroate as a 21 mg dose and 22 mg of vilterol and 3 mg of trifnatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is sodium "), magnesium stearate
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme inhibitor ( rtrti ). these active substances are all given together with antiretroviral medicines . how atripla works atripera works by interfering with the normal working of an enzyme ( reverse transcriptasing ) that is essential
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) have been reported with the use of atripola in elderly patients . if you take more atriplea than you should if you accidentally take too many atriblea tablets , contact your doctor immediately . if possible , take your tablet with you . you
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavenirenz and 200 mg emtracitabINE and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atribla contains sodium ").
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadonotrophins releasing hormone ( gnrh ). release of gonadotropins is a natural hormone that stimulates follicle stimulating hormone . gonadots play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells in the sacs . they are then collected and given to you by your doctor . they then
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions if you experience allergic reactions ( generalised , hives , urticaria
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is intended for use in women who are undergoing the treatment of assisted reproduction techniques , including in vitro fertilisation ( ivf ), ovarian stimulation ( follicle stimulating hormone ), corifollitropin on day 2 or 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . orgallutran can be used in women whose fsh is not fully controlled . the preparations are given in different injection sites . daily treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . this is uncommon ( may affect up to 4 in 1 , 100 people ). other side effects are : headache nausea ( malaise ) very rare ( may affects up to 1 in every 10 , 000 people ) allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). syringes should be clear , liquid - free solutions . do away with any unused solution after first opening . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( see section 2 ). - the ph is sodium hydroxide and acetic acids . what orgalUTran looks like and contents of the pack orgaluitran is a clear , colourless aqueous solution for subcutaneous administration . the solution is clear and colourless . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , it stops the cell from growing and dividing . what blitzima used for blitzima has been prescribed for the treatment of : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue that affects the immune system . it affects a type a of white blood cells called b -
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . - if he / she has a weak immune system . - warnings and precautions talk to your doctor or pharmacist before using blitzima if your baby has severe heart failure or severe uncontrolled heart disease . warnings and risks talk to the doctor or nurse before using this medicine if your newborn has granulomatosis , polyangiitis , microscopic polyangiaitis or
how blitzima is given your doctor will decide how much blitzima you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may reduce your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor can also change the dose of your treatment . for non - hodg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found in the cells of the body and helps to reduce the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in the joints caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease that has not responded to previous therapies . roac
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor or nurse before the infusion with roactema . allergic reactions may include chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . your doctor may decide to slow or stop the infusion . infection if you get infections , tell your doctor immediately . if you feel unwell , your doctor will decide whether to continue with roctem
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will decide on the correct dose based on your body weight . the treatment will be started by a doctor or another healthcare professional . the recommended dose of roactema is 8 mg / kg body weight once a day for 4 weeks . your doctor will decide how many weeks you should receive roactemera . the first 4 weeks are given as a drip in the vein ( intravenous infusion ) and the second week are given 2 weeks . the maximum recommended dose is 30 mg /kg body weight
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking the medicine ( see section 3 " warnings and precautions "): stop taking roactamra and tell your doctor straight away if you notice any of the following serious side effects : common ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin bl
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vinal contains 400 mg of the active substances tocilixumab , 20 mg per ml . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezezhalzer is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if the patient has heart problems , epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). treatment with on brez breezerhaler may cause you to develop tightness of the chest , coughing , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram twice a week depending on how you respond to the treatment . your inhaler will be used 24 hours after you last inhaled it . how to use onbrez breezhaler you will find an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ). the onbreez breez inhaler contains the medicine and capsules are provided in separate blisters
what onbrez breezhaler contains - each onbreez breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule contains gelatin . - eachonbrez bronzhalER 300 microgramS inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol as indiacatholmaleate . - the ingredients are : lactose or the capsule contain gelatin . what onbrex breezeler looks like and contents of the pack onbre
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs - if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of clopridogrel ccs , ask your doctor or pharmacist . warnings and precautions take special care with clopIDogrel clcs if you :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had : - severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ) - severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . your doctor may decide to stop fetcroje if you had
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours and may take up to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your infection will be treated as soon as possible . you should not feel any pain during the fetcroJA infusion . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if you have kidney problems tell your doctor if you are having kidney problems . if your doctor determines that you are
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : - severe allergic reaction : - sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement . other side effects if you get any of these side effects : tell your physician or pharmacist . the following side
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is activated by the immune system and is used in adults to destroy lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not be given any dexamethasone tablets to treat unwanted effects . if your side effects do not improve or get worse , tell
before starting treatment of cancer , the doctor will have placed the vial in a lumber sac . depocyte will be given to you by a doctor or nurse . the recommended dose of depocyte is one vial of 1 mg or 5 mg of dexamethasone per day . the dose may be increased or decreased depending on your response to depocyte and on any side effects that you experience after receiving depocyte . the usual dose is one injection ( 1 mg ) in the morning followed by one injection of 5 mg in the evening . the doctor may increase the dose to one injection in the afternoon followed by two injections in the
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare cases : very rarely ( affects fewer than 1 in 10 users ). reporting of adverse events if you get any side effects talk to your doctor or pharmacist . depocyte with other chem
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this to protect from light . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarbine . one vial of 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylosphatidoglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . it is supplied in a 5 ml glass vial as a single injection . each pack contains one
what bemrist breezhaler is bemist breez inhaler contains two active substances : indacaterol and mometasone furoate . indacasterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing problems . cort
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to any of these active substances . - if your doctor has told you that you have heart problems . - that you develop an irregular or fast heartbeat . - you have thyroid gland problems . warnings and precautions talk to your doctor or pharmacist before using bemrid breez inhaler if you have diabetes , high blood sugar , seizures or low level of potassium in your blood . - tell your doctor if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with a glass of water . you can take bemist breez inhaler with or without food . try to take the medicine at the same time each day . it is important that you continue to take it until your asthma is controlled and your symptoms improve . if you have the impression that the effect of bemrid breezhhaler is too strong or too weak , talk to your doctor . be mrist breezezhalzer
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of your tongue , the lips , face or throat ( angioedema ). other side effects other sideeffects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation contains 173 microgram indacate . each capsule contains 150 microgram of indacatesol and 80 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microlitres ( i . e ., one inhalation of indaceaterol ) and 62 . 75
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is taken to prevent blood clumps ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). zllt is taken by adults
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking this medicine . if : you have bleeding such a medicalcondition that puts you at risk of internal bleeding ( such as : a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one one 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating ; tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating .
lamivudine teva contains the active substance lamivudrine . lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine seva lowers the amount of hepatitis b in your liver and so reduces the risk of compensated liver disease
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuine tevas , like other similar medicines , can cause serious side effects , especially if you have liver disease ( such as hepatitis c . if you become overweight , you may need extra check - ups ). your doctor will do blood tests before you start your medication . see section 4 for more information . do not take more lamivUDine tella than your doctor tells you to . if your hepatitis is not being treated with lamiv
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor will prescribe the best dose for you . lamivudine teva is used to treat your hepatitis b infection . it is important that you take the tablets exactly as described in this leaflet . you can take lamivu teva with or without food . it does not matter whether you take them with or with food . if you take more lamivudiine tella than you should if you accidentally take too many tablets of lamividine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in clinical trials for other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b were : side effects that have been observed during lamivuine clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes . these are seen as signs of an increase in enzymes in the muscles . allergic reaction ( rare , may affect up to 1 in 1 ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivuvine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed with " l
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by interfering with the natural hormone erythropoietin . erythroietin works by helping your kidneys to produce more red bloodcells . it is also given to you by your doctor to increase the number of red blood cell cells ( darbepoetin alfa ) in your blood . chronic renal failure is the most common form of symptomatic
do not use nespo : if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using nesp : if your child has high bloodpressure or is taking medicines for sickle cell anaemia . if your baby has epileptic fits ( seizures ). if your newborn has convulsions ( fits ). if you suffer from seizures . if he / she has liver disease . if any of the above applies to
your doctor will carry out blood tests before you start using nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemoglobulin level of 10 mg every 12 hours using the pre - filled syringe . nespos is given intravenously ( into a vein ). patients with chronic renal failure , a single injection is given under the skin into a veins ( intravenous ). your doctor may decide to inject nesco yourself . your anaemia will be monitored by your doctor . your dose of nespol will be calculated based on your body
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 1 in 10 people ) uncommon ( may effect up to 1 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may affects up to1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare : ( frequency cannot be estimated from the available data ) very rare ( may affecting up to one in 10 ,
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening , nespos may be stored for a maximum of 30 days in the outer carton , in order for it to reach room temperature ( up to 30 ) and to be used within 7 days . do this at the end of this
what nespo contains the active substance is darbepoetin alfa . each ml of solution contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances are darbasepoetein ala and alfa - 2b . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e415 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nespi is a
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of adults with macular dementia . in this disease , vision loss occurs due to damage to a part of the retina called the macula ( the coloured part of your eye ). macula is the thin layer between the two layers of the eye called the ' macula ' and is the eye ' s largest layer . abnormal blood vessels grow in the retina and become larger , blocking the macular
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has an active or suspected infection in the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in theeye , stop using macug injection and contact your doctor immediately . if your newborn has any of these , tell your doctor . if the newborn has the following symptoms : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to light small particles in your
mugen will be given to you by a doctor or nurse who is experienced in giving injections of macugen . macugen is given as a single injection into the eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye ( the coloured part of your eye ). macugen must be used every three weeks . antibiotic eye drops will be applied to the affected eye . your doctor will clean your eyes with some local anaesthetic ( numbing medicine ) to prevent any pain that may be caused by the injection . if you are allergic to antibiotic eyedrops , you should not receive
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine immediately after first opening . do away with the blister if you notice any change in the appearance of the tablets . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre - packed syringe (
palifermin belongs to a group of medicines called escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract , which are tissues that line the skin . paliformin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that can be treated with treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( which can destroy blood cells ) it may be more likely that you will be given
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepvelance may affect the way heparin works . if you recently taken heparrin , tell your physician . pregnancy and breast - feeding kepervance is not recommended if you plan to become pregnant . if pregnant ,
how kepivance is given your doctor will decide on the dose you will receive . your doctor or nurse will calculate your body surface area in square meters ( mÂ² ) and will determine the dose that you will be given . the usual dose of cancer treatment is one 60 mg tablet of kepvance per kilogram body surface surface area . the recommended dose is an intravenous injection into a vein . how kepvelance is administered kepovance is usually given to you three days before chemotherapy ( chemotherapy and radiotherapy ) in three different phases : chemotherapy , radiotherapy and radiotherapy 24 to 48 hours after
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decreased levels of digestive enzymes in theblood . treatment usually lasts
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitib , which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , just below the thyroid gland . cinaconcet accordpharma is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or whose thyroid gland is not working properly . to reduce the amount of calcium in the bloodstream ( hypercalcaemia ) in patients with parathyrot
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking cicalcut accordpha : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of seizures (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken twice a day , with or just after meals . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual dose of cinocalcordpharma is 30 mg once a day ( morning and evening ).
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every 10 people )
what cinacalcet accordpharma contains - the active substance is cinacetalcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacealcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcordpharma looks like and contents of the pack cinaciaal
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformatin belongs to the group of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or emp
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you ( or you are not sure ), tell your doctor . - uncontrolled diabetes ( with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lacticacidosis " below ). what is ketoacidosis ? keto acidosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metformatin , take this medication at the same time each day . if this medicine does not work well enough to control an upset stomach , take it at the usual time . the recommended dose is one 5 mg linaglptin tablet once a day . your doctor may prescribe a higher or lower dose of 2 , 000 mg metforma hydrochloride once
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentADueto plus sulphonylurea may cause lactic acidosis ( coma ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforma hydrochlorides . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentADueto looks like and contents of the pack jentaden
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hiv medications to treat adults and adolescents aged 12 months and older infected by hiv . it is not recommended to switch from hiv medicine to edurent without first talking to your doctor . medicines should not be given at the same time as edurANT
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurants if you : - are taking any of any of : - the following medicines : carbamazepine , oxcarbazepine or phenobarbital or phenytoin - medicines used to treat some bacterial infections ( e . g . tuberculosis ) - omeprazole , esomeprazole or lansoprazole - pantoprazoles or rabepraz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( 18 years of age and older ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet twice a day with food . do this if your doctor tells you to . do the following : - take rifabutin ( a medicine used to treat some bacterial infections ). edurants can be taken with or without food . - take edurent with rifabilutin . if you take more edurutant than you
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia , dizziness , and changes in your routine liver tests may occur . decrease in transaminase ( a protein produced by the body ), increase in cholesterol and pancreatic amylase ( an enzyme produced by your body ) in your blood . abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your
what edurant contains - the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpivira hydrochlorine equivalent to 25 mg rilpelirine - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating :
avandamet tablets are taken together with two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin or their body does not make enough of a insulin to control their blood sugar levels . rosigllitazONE and met formin work together by helping the insulin work better , and lower your blood sugar . avandamter is also used as a sulphonylurea ( a type of diabetes medicine ) in adults and adolescents .
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . how to treat your diabetes your doctor will tell you what to do if you have any of the following conditions : avandamet should not be used : - if you were born with or have had a heart attack - if your doctor has told you that you have severe angina - if any of these apply to you - if the patient has had heart failure in the past - if he or she has severe breathing difficulties - if patients with liver disease
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( 1000 mg ) metformin twice a day . this dose is taken once a day , at least 1 hour apart from the time of the day . from the morning until the evening , take the tablet at about 8 o 'clock . the maximum dose is 4 mg rosciglitrazone ( 600 mg ) once a morning , at about the same time each day . your doctor will tell you the
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build - up of lacticacid in the blood ( lactic acidsosis is a common side effect of metformin in patients with severe kidney disease ). symptoms of lact acidosis include rapid breathing , cold stomach
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg ) metforman , and 2 mg rosciglitasone ( 500mg ) met formin . each 2 mg tablet contains rosigslitazona ( 1000 mg ) and met formformin , and each 4 mg tablet contain rosIGlitazion ( 1000mg ) and meetformin ( 20 mg ). the other ingredients are sodium starch glycollate , hypromellose
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidsogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel mylan 31 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you : have a risk of bleeding such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogl ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopide mylan contain hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl 3000 .
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), in adults , adolescents and children . it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not take doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking doptelelet if : you have ever had blood clots in the veins or arteries ( which may increase the risk of blood cl clots ) you have cancer you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are seriously injured 23 you are overweight or have advanced chronic liver disease you are not sure if any of these apply to you . children and adolescents do not give
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on your body weight and will base the dose you need to take during your procedure . the usual starting dose is 5 mg once a day . your dose may be increased to 8 mg once daily depending on your response to doptelet . your daily dose of doptelets may be adjusted to 20 mg , 40 mg , 60 mg or 5 mg per day depending on the severity of your platelet counts . your physician will tell you how many tablets of this medicine to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate . - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for diagnostic use : - to perform a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using the muscles in the heart using a readmill . a scan is taken to measure the amount of a small amount of radiopharma that is being absorbed into the body through a vein ( usually in the hand ).
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker that does not work properly , chest pain ( unstable angina ), or treatment for low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before using rapiscen if you : have a recent serious heart problem , including a heart attack , have abnormal heart rhythms ( a heart rhythm where the heartbeat is very fast or uneven , atrial flutter
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 to 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over the same period of 5 minutes . if you are given a radioactive substance ( radiopharmaceutical ), the dose of rapiscan is
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given at least 30 minutes after any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . if you have any of these , tell your physician immediately . if
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . if you have been taking any of these medicines ( see " other medicines and viagra " below ), you should tell your doctor immediately . - if there is a risk of angina pectoris ( " chest pain ") that you have not been adequately controlled with the medicines listed above . - in patients who have been prescribed nitric
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are for oral use . viaga orodispersible tablets are also for oral administration . swallow the tablets whole with a glass of water . viagagra can be taken with or without food . viago can be used if you have an erection , or if you feel sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take viagra with food .
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been reported with viagra . the following side effects have been experienced with viaga : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur if you are in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur up to one in 1 , 000 people ). if you
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat the symptom of moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol . - if your doctor has told you that you have any medical conditions or symptoms of kidney disease . - tell your doctor if you have hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may cause dys
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg per day ). your doctor may increase your dose to 1 tablet sifol 0 . 010 mg ( 1 . 264 mmol per day ) if your symptoms return but do not stop taking tablets until your doctor tells you to . the usual maintenance dose is between 1 and 3 tablets of
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), - dizziness , - nausea ( sickness ), - urge to behave in an unusual way - hallucinations ( seeing , hearing or
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole as 0 . 125 mg , 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 8 mg , 10 mg , 15 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 100 mg , and 200 mg . the other ingredients are : tablet core : mannitol , maize starch , anhydrous colloidal silica , pov
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur when the surface of the eyeball is damaged or opened . the allergic reaction may be severe . allergic conjjunctivis may occur when you are exposed to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling . if this happens on the surfaceof your eye , you may not feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadadine . children and adolescents do not give this medicine to children under the age of 3 years because benzalkonium chloride is present in the blood in children and young people . emadin should not be used in children under 6 years of age . clinical trials have not been performed in children . use in children or adolescents there is no experience with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults ( 12 years of age and older ) and children ( 12 to 17 years of years ) use in the same eye . this medicine is for oral use . use in both eyes . use the recommended dose in children ( 6 to 17 year of age ) and adolescents ( 12 - 17 years ) using the emadine bottle . wash your hands before using it . remove the bottle from the
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate and will usually disappear after a few weeks . if the drops do not work well enough , tell your doctor . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing staining and dry
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels ( ph levels ). what emadINE looks like and contents of the pack emadrine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . each bottle contains one bottle .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levevetirateam is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). leetiracetams has
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems . - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported . - if your child is taking anti - epileptics , levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your physician if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet of 1 , 000 mg once a day ( monotherapy ) the usual starting dose is 3 , 000mg once a week . your doctor may increase your dose to one tablet once a month ( monotherapies ) of levetiraacetam actingavis ( 2 tablets of 1, 000 mg ) once
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms , a rash on the face with an extended rash , a high temperature and increased levels of liver enzymes seen in blood tests ( a decrease in a type of white blood cell 56 ) in patients with eos
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each film - coated tablet contains 250 mg of levetmiracetam ( as levetoracetam ). levetieracetam actingavis 500 mg : one film - coating contains 500 mg of the active ingredient levetirusacetam , as levantiracetaman actavis 750 mg : two film - coatings contain 750 mg of of leveriracetamine ( as besilate ). leverieracetarm actavis 1 , 000 mg : the active substances are
celemide contains the active substance umeclidinium bromide which belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked . this makes breathing difficulties difficult . incrose ellipte works by reducing the amount of air that gets in and out of the lungs . this helps to control your breathing difficulties . it also helps to reduce the amount that you have to inhale . if you have copd , this medicine will help
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using incrusey ellipta : if you have asthma . incruche ellipta should not be used if you suffer from asthma . if you smoke . if your doctor has told you that you have heart problems . if any of these apply to you , tell your doctor . if there is an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use incruse ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more incruce ellipta than you should if you have used more inculse ellipte than you need , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose , throat cough feeling of pressure , pain in the cheeks and forehead these may indicate inflammation of the sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the seal should be replaced . do away with the inhalER after 30 . do this once the seal has been
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramms umelidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemella contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body , a light green mouthpiece
what nucala is nucal contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to specific receptors in the body . what nucalan is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the lungs to open ) and eosinaophilic asthma . how nucalo works in asthma nucalin helps to control asthma attacks by stopping the production of medicines called high
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to stop nucal or stop your treatment with nucalan . if your asthma does not respond to nuca treatment , your physician may decide not to continue nucla . allergic and injection site reactions medicines of this type ( monoclonal antibodies ) cause severe allergic reactions to other parts of your
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . the recommended starting dose is 1 mg once daily . you may inject nucala in the pre - filled pen once a day . duration of treatment with nucal your doctor will decide how long you should continue to receive nucla . your doctor may decide to interrupt or stop the treatment with a short break in the treatment . if you use more nucale than you should if your asthma symptoms are worsening or attacks occur , your doctor should treat your asthma
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) the injection may not be fully effective and may cause you to feel dizzy or lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the following reactions seen with nacala . other side effects very common side effects ( may affects more
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 3 8 ). discard the pre filled pen if it has not been used within 7 days . do throw away any medicines via wastewater or household
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 mg is a clear , colourless solution . it is supplied in a pack containing 1 ampoules or in a multipack containing 3 ampouls
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ix azomib is used in patients for cell survival because myelomas cells contain a lot of proteins called proteasomes . how ninlalo works when used in combination with other medicines , it can help to treat multiple myelo . how it works multiple myelinoma is a disease of the blood . it can occur when the plasma cell is damaged
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions , please tell your doctor . warnings and risks talk to the doctor or nurse before taking this medicine . if any or all of these applies to you , tell your physician or pharma before taking the medicine . stop taking ninlanaro and seek medical help immediately if you experience bleeding , persistent nausea , vomiting , diarrhoea ,
you must not be given ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlar is lenalidomide ( a medicine that contains dexamethasone ), an anti - inflammatory medicine . how to take ninlara take lenalidome and dexamETHasone once a day for the first 3 weeks . you will take the first 4 weeks of lenalidimide 25 mg capsules on the first day of the week . you may take dex
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the entire body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . do away with the capsule after the first use . do this medicine only if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib and 3 . 3mg ixabomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg / ixezomib ( 4 . 3 millig
do not use palforzia if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palfORzia ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers aged 4 to 17 years because treatment with peanut allergy is not recommended . peanut ( desensitisation ) is not a cure for peanut allergy . palfiorzia does not cause allergic reactions . poforzias is not indicated for the treatment of food allergies . if you have any further questions on the use of paforziosis , ask your doctor
do not take palforzia if you are allergic to peanut or soya . if you have severe asthma . if your asthma is worsening or you have a problem swallowing . if this applies to you , tell your doctor . if any of the above applies to your child , tell the doctor before taking palfourzia . warnings and precautions talk to your doctor or pharmacist before taking this medicine if your child has : long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if the symptoms of severe anaphyaxis occur within 60 days of starting
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and allergy if you have allergic reactions ( anaphylaxis ) to palforzia , your doctor will discuss with you the potential risks and benefits of taking this medicine for 3 months . duration of treatment your doctor may prescribe palfourzia as initial doseescalation . these treatment steps are given as follows : the initial dose elevation and up - dosing steps are shown below . if you take more palfdorzia than you should if you accidentally take too many palfur
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : if you have any of the following symptoms while taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness or fainting , severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinoph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfofas . each 0 . 5 mg capsule contains 1 , 10 or 20 mg oral powder in capsules , with opening microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforsia 100 mg oralpowder in capsules with openingmicrocrystallose cellulose, colloidal anahydroussilica , and magnesium stearingate paldorzias 300 mg oral solution in sachet microcrystine celluloses , colloid anhydrated silica, magnesium stereate , and beige oral powder . initial
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions that help to control sleeping problems . zerene is for treatment of adults . it is used when treatment is not suitable or when you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing or chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . warnings and precautions talk to
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , you should take the capsule at bedtime . if your doctor tells you to take a lower dose , you may take the capsules at bed time . if the dose is 65 mg once daily . if this is not possible , you can take the dose at bedside . if mild to moderate liver problems are not possible you should continue with the dose recommended by your doctor . if it is not available , you will take the
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare , affects lessthan 1 user per 10 ,000 . not known ( frequency cannot be estimated from the available data ). very common : may
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( t171 ). capsule shell: gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide , ( s - 13050 ). printing
